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I. INTRODUCTION 
1. The Formation and the Prevention of Cancer 
1.1 Cancer in general 
Cancer - the uncontrolled growth and spread of abnormal cells – causes more than 
6 million deaths every year worldwide concerning almost any tissue of the human body. 
In industrialized countries, prostate, lung and colorectal cancer are the most common 
types in men, whereas breast and colorectal cancer appear to be predominant in females. 
Worldwide, colorectal cancer is the fourth common cause of cancer deaths after lung, 
stomach and liver cancer [Parkin et al., 2005]. 
Neoplasias can be caused by genetic as well as exogenous factors. To the current 
knowledge only 5% of all tumors are linked to genetic predisposition. Thus, in more than 
95% of all tumor formations environmental factors like tobacco smoke, alcohol, 
infections, nutrition and occupational exposure to carcinogens are involved [Becker & 
Wahrendorf, 1998]. With regard to this awareness, it appears desirable to inhibit cancer 
formation by preventive activities as far as possible. With more cancer prevention one 
would need less drastic medical interventions like surgery, radio- or chemotherapy and 
one would save costs in the health care system.  
 
1.2 Cancer Prevention 
Carcinogenesis is a multistage process involving individual steps including initiation, 
promotion and progression (Figure 1), and offers a considerable time frame for preventive 
agents to interfere [Pitot, 1993]. The initiation describes the transformation of one or 
more cells upon exposure towards exogenous or endogenous carcinogens. Usually pro-
carcinogens have low reactivity and they have to become activated by phase I enzymes of 
the biotransformation system of xenobiotics, which largely belong to the family of 
Cytochrome p450–dependent enzymes (CYPs) [Sheweita, 2000]. Activated carcinogens 
then react with and damage the DNA. These transformed cells undergo a promotion phase 
in which they hyperproliferate and accumulate additional mutations, leading to the 
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formation of pre-neoplasias. Yet, the process of promotion can be reversed. In the 
progression phase preneoplastic cells differ increasingly from normal cells with regard to 
morphology, function and growth behavior while they develop into a tumor that can 
become metastatic in advanced stages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Cellular carcinogenesis and chemopreventive mechanisms 
 
As shown in Figure 1, each step in the cascade of carcinogenesis can theoretically be 
inhibited, representing a target for preventional interventions.  
Primary cancer prevention involves the avoidance of cancer-causing behavior and 
exposure, whereas secondary prevention directs at the cessation of exposure to 
carcinogenic agents of individuals at risk as well as at screening to detect malignancies at 
an earlier stage. Tertiary chemoprevention focuses on the administration of agents 
intended to prevent the development of cancer and to inhibit or delay the occurrence of 
metastases [Zanker, 1999].  
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1.3 Chemoprevention 
Chemoprevention is a form of secondary prevention. The aim of chemoprevention as 
cancer management is defined as preventing, delaying or reversing carcinogenesis by 
intervention with nontoxic compounds, synthetic chemicals, or natural compounds before 
malignancy [Sporn & Newton, 1979]. 
Chemopreventive compounds taken in by humans should in general fulfill certain criteria: 
1. low costs and high availability, 2. activity following oral consumption, 3. high efficacy 
at achievable doses with little or no adverse effects and 4. a known mechanism of action 
[Katiyar & Mukhtar, 1996]. So far numerous natural compounds and synthetic derivates 
with potential chemopreventive efficacy have been identified. Some of them are already 
tested in clinical trials, e.g. retinoids against breast, selenium and vitamin E against 
prostate, fiber and calcium against colon, and green tea polyphenols against lung cancer 
development [Kelloff et al., 2006]. 
The compounds can be catagorized according to the stage of carcinogenesis they inhibit, 
initiation, promotion or progression. Tumor initiation, which is usually linked to DNA 
damage, can be reduced by so-called blocking factors. These are most effective when 
administered before the carcinogen. Blocking factors change the profile of phase I and 
phase II metabolizing enzymes. Further blocking mechanisms comprise the modulation of 
DNA repair rate or the scavenging of free radicals. So-called suppressing agents interfere 
with tumor promotion and progression by inhibiting cell growth of transformed cells or 
by inducing apoptosis. Thereby the accumulation of damaged cells is prevented (Fig. 1) 
[Wattenberg, 1992; Kelloff et al., 1994; Manson et al., 2000]. 
 
1.4 The role of nutrition in cancer formation and development  
Dietary behavior has been identified as one of the most important modifiable 
determinants of cancer risk. Thereby nutrition can influence cancer development in a 
positive, as well as in a negative way. For example, while a diet rich in saturated fats, red 
meat and alcohol is associated with an elevated cancer incidence, the consumption of 
fruits and vegetables is generally considered as protective against the development of 
different types of cancers [Steinmetz & Potter, 1991; WCRF & AICR, 1997]. However, 
evidence for a protective role of fruit and vegetable intake in cancer development varies  
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 Table 1:  Examples of chemopreventive compounds and their major mechanisms 
of action ([Surh, 2003] and literature cited therein) 
Compound Source Mechanisms 
EGCG  
 
Thea chinesis L. • inhibition of carcinogen 
activation  
• control of cell cycle and 
proliferation 
• induction of apoptosis and/or 
differentiation 
• inhibition of oncogene 
expression/activity 
genistein 
 
 
Glycine max L. • inhibition of carcinogen 
activation  
• stimulation of carcinogen 
detoxification 
• control of cell cycle and 
proliferation 
• induction of apoptosis and/or 
differentiation 
• inhibition of the activity of 
oncogene products 
• modulation of hormonal and 
growth-factor activity 
curcumin 
 
 
Curcuma longa L. • inhibition of carcinogen 
activation  
• stimulation of carcinogen 
detoxification 
• control of cell cycle and 
proliferation 
• induction of apoptosis and/or 
differentiation 
• inhibition of oncogene 
expression/activity 
diallyl sulfide 
 
 
Allium sativum L. • inhibition of carcinogen 
activation  
• stimulation of carcinogen 
detoxification 
• induction of apoptosis and/or 
differentiation 
resveratrol 
 
Vitis vinifera L. • inhibition of carcinogen 
activation 
• control of cell cycle and 
proliferation 
• induction of apoptosis and/or 
differentiation 
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considerably depending on the type of fruit/vegetable and the type of cancer. For 
example, of six case-control studies investigating the association of tomato intake and the 
risk of developing colon cancer, four showed a negative and two a positive correlation. In 
the case of citrus fruits, evidence is strong for a decreased stomach cancer risk, while the 
colon cancer incidence is elevated [WCRF & AICR, 1997].  
The impact of nutrition on cancer risk is further strongly affected by genetic 
polymorphisms, which can alter the response to dietary components by influencing the 
absorption, metabolism, or site of action. In order to understand the controversial 
outcomes from epidemiological and human studies, more research is needed in the fields 
of genetic polymorphisms and epigenetics, absorption, metabolism, distribution and 
excretion of dietary components, and interactions among dietary bioactive compounds 
and/or food combinations. Based on knowledge in these areas, future mechanistic in vitro 
and in vivo studies should be conducted in a more focused manner. 
Since approximately 35% of all cancer cases can be attributed to nutritional failures [Doll 
& Peto, 1981], cancer prevention by nutrition is of major importance. Chemopreventive 
compounds in food stuff mainly comprise micronutrients like secondary plant ingredients 
or vitamins. Examples of chemopreventive compounds are listed in Table 1. Through the 
identification of these compounds with screening tests and through the investigation of 
the molecular mechanisms responsible for their effects, targeted prevention of malignant 
transformation will be alleviated in the future.  
 
2. Brassica Vegetables and Cancer Prevention 
2.1 Brassicaceae and Glucosinolates  
Vegetables of the plant family Brassicaceae/Cruciferae are considered to be cancer 
preventive, mainly due to their content of glucosinolates [Jongen, 1996]. Many well- 
known sorts of vegetables are subspecies or variations of the genus Brassica oleracea. 
These vegetables comprise white cabbage, red cabbage, broccoli, cauliflower, brussels 
sprouts or kohlrabi. A characteristic feature of this plant family is the occurrence of 
glucosinolates (thioglucosides). Glucosinolates are secondary plant ingredients with a 
common basic structure consisting of glucose, a sulfur-containing group with an aglycon 
residue and a sulphate group (Fig. 2).    
I. Introduction                                                                                                                     6 
 
 
 
 
 
 
 
Fig. 2: General structure of glucosinolates and their cleavage by myrosinase (adopted 
from [Krul et al., 2002]) 
 
So far more than 120 different glucosinolates have been identified, 10 to 12 of them 
occurring in Brassica [Fahey et al., 2001]. They differ in the aglycon residue featuring 
alkylic, alkenylic, arylic or indolylic structures. Hydrolytic cleavage of glucosinolates 
mainly leads to the formation of reactive isothiocyanates (ITCs) which are responsible for 
the hot and bitter taste of radish or mustard. In evolution glucosinolates serve as a 
protection against being eaten as well as against pathogens. The enzyme myrosinase 
(thioglucoside glucohydrolase EC 3.2.3.1.) is responsible for thioglucosidases cleavage. It 
is located separate from its substrates in a different plant cell compartment. Once the plant 
cell is destroyed mechanically (e.g. by chewing or cutting) glucosinolates are broken 
down enzymatically. Thereby the glucose molecule is released, resulting in an instable 
intermediate, which is rearranged forming isothiocyanates, thiocyanates and nitriles. 
Formation of the latter two depends on pH and on the presence of heavy metals (Fig. 2) 
[Krul et al., 2002]. ITCs from indolyl glucosinolates like glucobrassicin are chemically 
instable and are rearranged forming indole-3-carbinol and other indole derivates.  
The outcome of glucosinolate cleavage by myrosinase is further dependent on the 
presence and activity of epithiospecifier protein (ESP) which has been found in several 
brassica vegetables [Foo et al., 2000]. ESP directs myrosinase-catalyzed hydrolysis of 
alkenyl glucosinolates toward epithionitrile formation.  
The glucosinolate content of Brassicaceae ranges from 150 to 5000 mg/kg fresh weight. 
It depends on the species and variation, as well as on the conditions for growth, 
maturation and storage. In addition, the glucosinolate content varies between the different 
plant organs. Highest levels are found in sprouts [Fahey et al., 1997; Verhoeven et al., 
1997].   
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2.2 Uptake and Metabolism of Glucosinolates 
ITC bioavailability from brassica vegetables ranges from 10 to 90% and depends on 
several factors [Holst & Williamson, 2004]. Glucosinolates cannot be absorbed from the 
intestine due to their water solubility. In contrast, glucosinolates cleavage products have a 
high bioavailability. The enzyme myrosinase is solely present in the plant itself as well as 
in the gut microflora. Glucosinolate cleavage in the human body is therefore restricted to 
the colon. Hence, systemic uptake and exposure of different organs to ITCs strongly 
depends on the preparation of brassica vegetables prior to consumption.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Determinants of ITC bioavailability  
 
Chopping and chewing of raw vegetables leads to a relatively high systemic uptake of 
ITCs, whereas cooking inactivates myrosinase and favors the uptake of intact 
glucosinolates, leading to a topological exposure toward glucosinolate cleavage products 
in the colon [Conaway et al., 2000; Shapiro et al., 2001; Johnson, 2002]. The length of 
this direct exposure is however unclear and is probably limited due to intestinal transit. 
Figure 3 shows a scheme of ITC bioavailability in the gastrointestinal tract. 
One additional determinant of ITC bioavailability is the activity of ESP in some brassica 
vegetables. While nitrile formation can be favored when raw vegetables are consumed, 
Bioavailability of ITCs: 10-20%
(without consideration of cooking losses)
Intake of glucosinolates       
(cooked vegetable)
Intake of ITCs                               
(raw vegetable)
Bioavailability of ITCs: 30-90%
(depends on chewing/chopping)
glucosinolates partly converted to ITCs by gut microflora  → absorption 
colon
no absorption absorption of ITCs
small intestine
→ topological exposure 
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mild heat treatment abrogates ESP activity so that ITCs are formed exclusively 
[Matusheski et al., 2006].    
 
Following absorption ITCs are rapidly metabolized by the mercapturic pathway, as 
depicted in Figure 4. An initial conjugation with glutathione (GSH) promoted by 
glutathione-S-transferases (GSTs) gives rise to the corresponding GSH-ITC conjugates. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: Metabolism of ITCs via the mercapturic acid pathway [Shapiro et al., 2001] 
 
These undergo further enzymatic modification to give rise sequentially to the 
cysteinylglycine-, cysteine- and N-acetylcysteine-ITC conjugates, the latter being 
excreted in the urine. After consumption of brassica vegetables urinary excretion of the 
corresponding dithiocarbamates peaks between 2 and 4 hours. The amount of excreted 
ITC-metabolites directly correlates with the amount of ITC taken up [Chung et al., 1998; 
Getahun & Chung, 1999].  
 
2.3 Epidemiology 
Five out of seven prospective cohort studies on the association between the consumption 
of brassica vegetables and cancer risk showed a protective effect [van Poppel et al., 
1999]. Another overview of cohort studies in relation to colorectal cancer and 
Brassicaceae demonstrated that out of twelve studies eight disclosed an inverse, three 
none, and one a positive correlation between the intake of cruciferous vegetables and 
excreted in urine
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colon cancer risk [Steinmetz & Potter, 1996]. 67% of case-control studies reported of a 
correlation between brassica vegetable consumption and a decreased cancer risk, whereby 
this coherence was strongest for lung, colon, rectum and stomach [Verhoeven et al., 
1996].  
More recent studies provide evidence that cancer risk can substantially be influenced by 
genetic polymorphisms of drug-metabolizing enzymes, together with the consumption of 
cruciferous vegetables. This is due to the fact that ITCs are not only metabolized by 
GSTs, but can also induce phase II-enzyme activity and gene expression, which leads to 
enhanced detoxification rates [Zhang & Talalay, 1994; Pool-Zobel et al., 2005]. 
Especially the effect of GSTM1- and GSTT1-null polymorphisms on cancer risk in 
relation to brassica vegetable intake has been investigated, since these gene defects are 
relatively common in humans [Wiencke et al., 1990; Pemble et al., 1994]. The frequency 
of the homozygous null genotype of GSTM1 varies between 39% and 63%. The 
homozygous null GSTT1 genotype can be found in 10% to 21% of the Caucasian 
populations, while in some Asian populations the frequency can be as high as 64% 
[Cotton et al., 2000]. Epidemiological studies conducted in the United States have 
concluded that GSTM1-positive persons gain greater cancer protection from either 
broccoli consumption or total cruciferous vegetable consumption than do GSTM1-null 
persons [Spitz et al., 2000; Joseph et al., 2004; Wang et al., 2004]. In contrast, studies 
conducted in Asia concluded that GSTM1- and GSTT1-null persons may profit more from 
crucifer consumption than do GSTM1- and GSTT1-positive persons [London et al., 2000; 
Zhao et al., 2001; Fowke et al., 2003; Seow et al., 2005]. The major cruciferous 
component of the diets in these Asia-based studies would have been Chinese cabbage, as 
opposed to broccoli. Moreover, the predominant isothiocyanate derived from broccoli, 
sulforaphane, is mainly metabolized by GSTM1-1, which may be one explanation for the 
observed discrepancies [Kolm et al., 1995; Zhang et al., 1995; Gasper et al., 2005]. In 
summary, whether subjects with GSTM1- or GSTT1- null-polymorphisms, or subjects 
positive for either gene are more protected against cancer formation depends on several 
factors like the ethnical origin as well as the amount and type of cruciferous vegetables 
consumed.  
   
 
I. Introduction                                                                                                                     10 
 
DIMSFN
N
H H
NS
O
N C S
2.4 Sulforaphane and 3,3’-Diindolylmethane: two promising cancer 
chemopreventive compounds from brassica vegetables   
 
Of all known glucosinolate cleavage products sulforaphane (SFN) and 3,3’-
diindolylmethane (DIM) are among the most promising and intensively studied 
substances. The chemical structures of SFN and DIM are depicted in Figure 5. SFN is an 
aliphatic ITC derived from the glucosinolate glucoraphanin, which is found in substantial 
quantities in broccoli. DIM on the other hand is a dimeric condensation product of indole-
3-carbinol, which is derived from the indolyl glucosinolate glucobrassicin, present in 
most cruciferous vegetables. Because of the different chemical nature of these two 
compounds and because both concomitantly occur in broccoli, SFN and DIM were 
chosen to be investigated in the present thesis regarding their anti-proliferative potential.  
 
 
 
 
 
 
 
Fig. 5: Chemical structures of sulforaphane (SFN) and 3,3’-diindolylmethane (DIM) 
 
2.4.1 Sulforaphane  
In 1992, Zhang et al. initially identified sulforaphane (SFN) as a principal inducer of 
phase II enzymes including NAD(P)H:quinone oxidoreductase in broccoli [Zhang et al., 
1992]. In the following years numerous studies demonstrated SFN’s potencies to 
modulate carcinogen metabolism via inhibition of phase I (CYPs) and induction of phase 
II enzymes [Talalay & Zhang, 1996]. Due to its feature to induce the expression of phase 
II- but not of phase I enzymes, SFN is a so-called monofunctional inducer [Prestera et al., 
1993]. The underlying mechanism involves an electrophilic interaction with cysteine 
residues of Kelch ECH associating protein 1 (Keap1), which leads to the liberation of the 
transcription factor nuclear factor-E2-related factor 2 (Nrf2), culminating in the induction 
of phase II enzyme genes and antioxidative stress protein genes via the antioxidant 
response element (ARE) [Talalay et al., 1995; Dinkova-Kostova et al., 2002]. 
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Cancer preventive activity of SFN could be proven in several animal models. SFN 
inhibited 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis in 
rats, azoxymethane-induced colonic aberrant crypt foci formation in rats, benzo[a]pyrene-
induced forestomach cancer in mice, DMBA-induced skin tumorigenesis in mice and 
intestinal adenoma formation in ApcMin/+ mice [Zhang et al., 1994; Chung et al., 2000; 
Fahey et al., 2002; Hu et al., 2006; Myzak et al., 2006; Xu et al., 2006].   
Apart from the ability of SFN to block initiation of carcinogenesis by modulation of drug 
metabolism it can also interfere with tumor promotion. One way of suppressing 
carcinogenesis in the promotion stage is by anti-inflammatory mechanisms. In cultured 
cells, SFN was shown to inhibit the activation of nuclear factor-κB (NF-κB), a 
transcription factor regulating a series of proinflammatory and prosurvival genes [Heiss et 
al., 2001; Heiss & Gerhauser, 2005; Xu et al., 2005]. On the other hand, 
immunomodulatory activity of SFN in mice was reported, in that markers indicating a 
fortified immune system were increased after administration of SFN [Thejass & Kuttan, 
2006; Thejass & Kuttan, 2006]. An effective way to interfere with tumor growth is to halt 
cell cycle progression in cancer cells by the induction of a cell cycle arrest, either in G1 or 
in G2/M phase. SFN was shown to mainly induce a G2/M cell cycle arrest in various cell 
lines. Moreover, the induction of apoptosis - programmed cell death - could be 
demonstrated after treatment of cultured cells with SFN [Gamet-Payrastre, 2006]. 
Another anti-tumor property was described for SFN: the inhibition of new blood vessel 
formation, angiogenesis. In the immortalized human microvascular endothelial cell line 
HMEC-1 SFN interfered with all essential steps of neovascularization [Bertl et al., 2006]. 
Also in human umbilical vein endothelial cells (HUVECs) SFN’s antiangiogenic activity 
could be demonstrated [Asakage et al., 2006].  
So far, mostly animal and in vitro studies have been conducted to investigate the anti-
cancer properties of SFN. One clinical phase I study was performed with broccoli sprouts 
that are known to have a very high content of glucosinolates, predominantly 
glucoraphanin [Shapiro et al., 2006]. In volunteers receiving daily doses of either 75 
µmol glucosinolates, 300 µmol glucosinolates or 75 µmol isothiocyanates from broccoli 
sprout extract for the duration of 7 days did not show any signs of toxicity. Thus, it is safe 
for humans to consume 50.4 g broccoli sprouts per day, which is equivalent to 300 µmol 
glucosinolates. 
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2.4.2 3,3’-Diindolylmethane – a condensation product of Indole-3-Carbinol 
Myrosinase-mediated cleavage of the glucosinolate glucobrassicin yields several indole 
derivates, of which indole-3-carbinol (I3C) is the predominant one [Fahey et al., 2001]. 
I3C is especially known for its cancer-protective effects in reproductive organs, both in 
vitro and in vivo, which are supposed to be due to the induction of specific CYP enzymes 
involved in estrogen metabolism [Bradlow et al., 1991; Kojima et al., 1994; Cover et al., 
1998]. In addition to the induction of phase I, I3C is also able to induce phase II 
detoxification enzymes, for which it is termed bifunctional inducer [Prestera et al., 1993; 
Shertzer & Senft, 2000]. Modulation of gene expression by indoles is known to take place 
via the aryl hydrocarbon receptor (AhR) that directly interacts with the xenobiotic 
response element (XRE), which is present in the regulatory regions of the genes for many 
phase II-, as well as phase I enzymes [Kim & Milner, 2005].   
Despite of the evidence for I3C’s chemopreventive efficacy a tumor-promoting effect of 
this indole derivate in animal models has been described as well [Pence et al., 1986; 
Bailey et al., 1987; Kim et al., 1997]. 
Under low pH conditions, as in the stomach, several condensation reactions of I3C occur 
which result in the formation of DIM as a major condensation product [Grose & 
Bjeldanes, 1992]. Therefore, it has been suggested that DIM and not I3C is responsible 
for the physiological effects of dietary indole-3-carbinol in vivo [Stresser et al., 1995; 
Takahashi et al., 1995].  
With I3C already several clinical trials have been conducted confirming the effect on 
estrogen metabolism by an increase of 2-hydroxylation of estrogens [Rogan, 2006]. 
Concerns have been raised that I3C might increase the formation of estrogen metabolites 
that induce or promote cancer, but this has not been demonstrated. 
In recent years, numerous in vitro studies have investigated the mechanisms responsible 
for the anticancer activity of DIM, apart from the well-described inducing effects on drug 
metabolizing enzymes. DIM was suggested to be an androgen-antagonist in human 
prostate cancer cells, it inhibited NF-κB activation and angiogenesis, stimulated 
interferon-gamma secretion, acted as a topoisomerase IIα catalytic inhibitor and potently 
induced cell cycle arrest in G1 phase as well as apoptosis [Aggarwal & Ichikawa, 2005; 
Chang et al., 2005; Rahman & Sarkar, 2005; Xue et al., 2005; Bhuiyan et al., 2006; Gong 
et al., 2006]. 
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Table 2:  Comparison of characteristics of SFN and DIM as chemopreventive 
agents 
 SFN DIM 
chemical structure aliphatic isothiocyanate indole derivate 
effects on xenobiotic 
metabolizing enzymes 
monofunctional inducer  bifunctional inducer 
mode of action on gene 
expression 
via Keap1–Nrf2 and ARE via AhR and XRE 
effect on the cell cycle G2/M arrest G1 arrest 
cancer sites most affected colon, rectum, lung, 
stomach 
hormone-dependent cancers 
(breast, cervix, prostate) 
 
Taken together, SFN and DIM, both derived from broccoli, exert their anticancer activity 
by different mechanisms. Table 2 gives an overview of the differences between these two 
chemopreventive compounds. 
 
3. Anti-proliferative Mechanisms for Cancer Prevention and 
Treatment 
Cancer cells are characterized by deregulated growth control, which can either be due to 
deactivating mutations in tumor suppressor genes or the activation of oncogenes. Genes 
belonging to these two classes of cancer-related factors are often associated with cell 
cycle regulation, apoptosis or signaling pathways involved in cell growth control like the 
NF-κB pathway. These pathways therefore represent targets for chemopreventive or –
therapeutic agents in order to interfere with uncontrolled tumor cell growth. 
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3.1 Arrest of the Cell Cycle 
3.1.1 Cell Cycle Regulation 
The eukaryotic cell cycle can be divided into four distinct phases. Mitosis and cell 
division occur during M phase (mitosis). This is followed by the G1 phase (for gap). G1 
gives way to the S phase (for synthesis) which is the period in the cell cycle when DNA is 
replicated. During G2 phase the now tetraploid cell prepares for mitosis. It then enters M 
phase once again and thereby commences a new round of the cell cycle. Many terminally 
differentiated cells, such as neurons or muscle cells, never divide; they assume a 
quiescent state known as the G0 phase.   
The progression of a cell through the cell cycle is regulated by proteins known as cyclins 
and cyclin-dependent protein kinases (Cdks). Cyclins are synthesized during one phase of 
the cell cycle and completely degraded during a succeeding phase. A particular cyclin 
specifically binds to and thereby activates its corresponding Cdk(s) to phosphorylate its 
target proteins [Voet & Voet, 2004]. The different cell cycle phases and the involved 
cyclin-Cdk complexes are depicted in Figure 6. 
3.1.2 Cell Cycle Checkpoints   
In order to enter a new phase in the cell cycle, a cell must satisfy a corresponding 
checkpoint, which monitors whether the cell has satisfactorily completed the preceding 
phase (e.g. the attachment of all chromosomes to the mitotic spindle must precede 
mitosis). If the cell has not met the criteria of the checkpoint, the cell cycle is slowed or 
arrested until it does so. If cellular damage or mistakes that have led to the cell cycle 
arrest are too severe, cells die via apoptosis.   
 
3.1.2.1 The DNA damage- or G2 Checkpoint 
The DNA damage checkpoint prevents cells from entry into mitosis when they experience 
DNA damage during G2. The result is an accumulation of cells in G2 to allow DNA 
repair. Sensors of the DNA damage checkpoint are the kinases ATM (ataxia 
telangiectasia mutated) and ATR (AMT- and Rad3-related), which activate the signal 
transduction pathway by phosphorylating the checkpoint kinases Chk1 and Chk2. Targets 
of Chk1 and Chk2 are members of the Cdc25 family of phosphatases that normally 
activate Cdk1, the cyclin-dependent kinase needed for the G2-M transition. 
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Phosphorylation of Cdc25 phosphatases results in their subcellular sequestration, 
degradation and/or inhibition so that the cyclin B/Cdk1 complex cannot be activated and 
cells are not able to enter mitosis [Kastan & Bartek, 2004].     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Cell cycle regulation. Refer to text for descriptions. M, mitosis; G0, Gap phase 0; 
G1, Gap phase 1; S, synthesis phase; G2, Gap phase 2; Cdk, cyclin-dependent protein 
kinases; Cdc, cell division cycle; R point, restriction point. 
 
3.1.2.2 The Spindle- or Metaphase Checkpoint 
The spindle checkpoint detects loss or impairment of functional connections between 
kinetochores and spindle microtubules during mitosis. Activation of the spindle 
checkpoint leads to a temporary or permanent cell cycle arrest in mitosis to allow time for 
correction of chromosome connections to the spindle. This is accomplished by the 
inhibition of the anaphase-promoting complex/cyclosome (APC/C), which controls 
mitotic progression and sister-chromatid segregation. The APC/C is an ubiquitin ligase 
complex that catalyzes polyubiquitinylation of a variety of targets including securin and 
mitotic cyclins like cyclin B1 during mitosis. The inhibition of the APC/C causes high 
cyclin levels, sustained Cdk1 activity, and prolonged mitotic arrest [Kops et al., 2005; 
Yamada & Gorbsky, 2006].  
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Dynamic microtubules continue to be one of the most successful cancer chemotherapeutic 
targets. Many new drugs that target microtubules are in clinical trials and large numbers 
of microtubule-active compounds are being developed. Microtubule-targeted antimitotic 
drugs are usually classified into two main groups. One group, known as the microtubule-
destabilizing agents, inhibits microtubule polymerization at high concentrations and 
includes several compounds such as the Vinca alkaloids (vinblastine, vincristine, 
vinorelbine, vindesine and vinflunine), cryptophycins, colchicine and combretastatins. 
The second main group is known as the microtubule-stabilizing agents. These agents 
stimulate microtubule polymerization and include paclitaxel (the first agent to be 
identified in this class), docetaxel (Taxotere), the epothilones, discodermolide and many 
more [Jordan & Wilson, 2004]. 
Mitotic arrest is usually followed by cell death which has been shown to involve 
apoptosis. Studies with cultured cells have even suggested that the spindle checkpoint-
mediated mitotic arrest may be a requirement for the subsequent cell death induced by 
antimitotic drugs. However, the precise signaling pathways connecting checkpoint 
activation and apoptosis initiation remain unknown [Yamada & Gorbsky, 2006].  
 
3.2 Apoptosis - Programmed Cell Death 
3.2.1 Apoptosis in general 
Apoptosis is the ability of a cell to eliminate itself upon external or internal signals. This 
programmed cell death is strictly controlled and involves different signaling cascades. 
Apoptosis is indispensable for the development of multicellular organisms. Mistakes in 
apoptosis regulation can have detrimental consequences. Too little apoptosis can result in 
cancer and autoimmune diseases, whereas neurodegenerative diseases are characterized 
by too much apoptosis [Thatte & Dahanukar, 1997; Fesik, 2005]. The term “apoptosis” 
(apo = from, ptosis = falling) has greek origin and describes the falling of leaves in 
autumn [Kerr et al., 1972].   
Apoptosis must be distinguished from necrosis, which is caused by external injury like 
mechanical damage. Characteristic morphological features of apoptosis include cell 
shrinkage, chromatin condensation, defined DNA degradation, membrane blebbing and 
the formation of several vesicles called apoptotic bodies, which are then phagocytosed 
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[Savill et al., 1993]. Necrosis on the other side is less orderly compared to apoptosis. 
Events during necrosis involve cell swelling, followed by disruption of the plasma 
membrane and release of the cytosolic content which results in an inflammatory reaction 
[Vercammen et al., 1998].  
Possible triggers for programmed cell death are DNA damage, cytotoxic T cells or 
nutrient deficiency. However, the initiation of apoptosis strongly depends on the cellular 
context and on the cell type. In general, apoptosis can be initiated via two different 
pathways, the extrinsic, death receptor pathway, and the intrinsic, mitochondria-mediated 
pathway (Fig. 7). Both pathways lead to the activation of the caspase cascade, which 
irreversibly results in cell death [Kim et al., 2002].  
Caspases (cysteinyl-aspartate specific proteases) are responsible for the execution of 
apoptosis. They are synthesized as inactive precursors (zymogenes) and activated through 
proteolytic cleavage, in most cases by upstream caspases in the caspase cascade 
[Thornberry, 1999]. Different caspases fulfill different functions during the initiation and 
execution of apoptosis. Initiator caspases like caspase-8, -9 and -10 transfer early 
apoptotic signals, whereas so-called effector caspases including caspase-3, -6 and -7, 
cleave cellular substrates, leading to the typical morphologic features of apoptosis 
[Earnshaw et al., 1999; Slee et al., 1999]. A very prominent substrate of effector caspases 
is the DNA repair enzyme PARP [poly (ADP-ribose) polymerase], the cleavage of which 
is considered as a hallmark of apoptosis [Soldani & Scovassi, 2002].    
3.2.2 The Mitochondrial Pathway 
The mitochondrial pathway of apoptosis induction is initiated by an internal stress signal 
resulting in the permeabilization of the outer mitochondrial membrane. This leads to the 
release of Cytochrome c and other proapoptotic factors like Smac/Diablo from the 
intermembrane space into the cytosol. Once in the cytosol, Cytochrome c participates in 
the formation of the apoptosome complex together with its adaptor molecule, Apaf-1 
(apoptotic protease activating factor-1), resulting in the recruitment, processing and 
activation of procaspase-9 in the presence of dATP or ATP. Subsequently, caspase-9 
cleaves and activates pro-caspase-3 and -7. The release of Cytochrome c is considered a 
key initiative step in the apoptotic process, although the precise mechanisms regulating 
this event remain unclear [Gogvadze & Orrenius, 2006]. 
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Proteins of the Bcl-2 family, which comprise pro-apoptotic (e.g. Bax, Bak) as well as 
anti-apoptotic (e.g. Bcl-2, Bcl-xL) members, are major regulators of the intrinsic pathway. 
They form homo- and heterooligomers, which act directly at the outer mitochondrial 
membrane. The ratio of pro- to anti-apoptotic oligomers has been suggested to play an 
important role in determining commitment to cell death [Kuwana & Newmeyer, 2003]. 
Further regulatory proteins involved in controlling the mitochondrial pathway of 
apoptosis induction include the family of inhibitors of apoptosis (IAPs), which bind and 
inhibit specific caspases. The IAPs themselves are also regulated by the IAP-inhibitor 
proteins like Smac/DIABLO (second mitochondria-derived activator of caspases/ direct 
IAP-binding protein with low pI) and HtrA2/Omi (high temperature requirement protein 
A2) [Armstrong, 2006]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: Apoptosis - Mechanisms of Initiation and Regulation. Refer to text for 
descriptions. DISC, death-inducing signaling complex; FADD, Fas-associated death 
domain; tBid, truncated Bid; Apaf-1, apoptotic protease-activating factor 1; Cyt c, 
Cytochrome c; ATP, adenosine triphosphate; PARP, poly (ADP-ribose) polymerase. 
 
 
I. Introduction                                                                                                                     19 
 
3.2.3 The Death Receptor Pathway 
The extrinsic pathway of apoptosis is induced by death receptors, a subgroup of the 
TNF1/nerve growth factor receptor superfamily. The best characterized member of the 
death receptor subfamily is CD95, also known as APO-1 or Fas. Stimulation of CD95 
with its cognate ligand, CD95L, leads to the trimerization of the monomeric receptor. 
This enables binding of the adapter molecule FADD/MORT1 and of procaspase-8 to 
CD95 via homophilic death domain and death effector domain (DED) interactions, 
respectively, forming the death-inducing signaling complex (DISC). Recruitment of 
procaspase-8 to the DISC leads to its proteolytic activation through several cleavage steps 
followed by direct cleavage of caspase-3 which in turn leads to apoptosis [Lavrik et al., 
2005]. Important regulators of death receptor-induced apoptosis are the c-FLIP proteins. 
c-FLIPs are recruited to the DISC by DED interactions and thereby inhibit procaspase-8 
activation [Golks et al., 2005; Golks et al., 2006].  
Apart from this direct pathway via caspase-8-mediated cleavage of caspase-3 (also called 
type I, mitochondria-independent pathway) a second possibility exists as a link between 
the death receptor- and the mitochondria-mediated pathway, which involves the Bcl-2 
family protein member Bid. Upon CD95-mediated stimulation activated caspase-8 
cleaves Bid resulting in truncated Bid (tBid) and the release of Cytochrome c from 
mitochondria, which is mediated by dimerizing with the proapoptotic Bcl-2 family 
member Bak (type II, mitochondria-dependent pathway) [Kim et al., 2002].  
 
3.3 Inhibition of Nuclear factor-κB  
The transcription factor nuclear factor-κB (NF-κB) plays a central role in cell 
proliferation, apoptosis and cancer development [Karin, 2006]. NF-κB consists of homo- 
and heterodimeric complexes formed from the Rel family of proteins, which consists of 
five proteins, named c-Rel, RelA (p65), RelB, NF-κB1/p50 and NF-κB2/p52. In 
quiescent cells the transcription factor is sequestered in the cytosol, but it rapidly 
translocates into the nucleus upon stimulation [Ghosh & Karin, 2002]. This process, 
known as NF-κB activation, can be initiated by two different signaling pathways. The 
classical NF-κB pathway involves p65 and p50 as well as the inhibitor protein IκB 
(inhibitor of NF-κB), which retains the p50:p65 dimer in the cytoplasm. Cell stimulation 
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activates the IκB kinase (IKK) complex, which is composed of two catalytic subunits 
(IKK-α and IKK-β) and a regulatory subunit (IKK-γ /NEMO) [Rothwarf & Karin, 1999]. 
Activated IKK phosphorylates NF-κB-bound IκB proteins, and targets them for 
polyubiquitination and rapid degradation by creating a binding site for SCFβTrCP ubiquitin 
ligase complex. Freed NF-κB dimers translocate to the nucleus where they coordinate the 
transcriptional activation of several hundred target genes [Karin, 2006].  
The second pathway of NF-κB activation, the alternative pathway, results in specific 
activation of p52:RelB heterodimers and is not required for activation of the more 
ubiquitous p50:p65 dimers. Unlike the classical pathway, which is dependent on IKK-γ 
and to a large extent on the activity of IKK-β, the alternative pathway is based on IKK-α 
homodimers, the preferred substrate of which is the precursor of p52-p100/NF-κB2. This 
protein binds RelB through its amino-terminal Rel homology domain, and keeps itself and 
its partner in the cytoplasm through its carboxy-terminal IκB-like domain. Activation of 
IKK-α homodimers results in degradation of the latter and nuclear entry of p52:RelB 
dimers [Senftleben et al., 2001; Karin, 2006].  
Signals that lead to NF-κB activation include many proinflammatory and prosurvival 
factors like LPS, inflammatory cytokines including tumor necrosis factor-α (TNF-α), 
interleukin-1 (IL-1), UV light or oxidative stress. Among the genes that are regulated by 
NF-κB are cyclin D1, vascular endothelial growth factor (VEGF), Bcl-xL, Bcl-2, c-FLIP, 
COX-2 and MMP-9, which are involved in a variety of cellular events including tumor 
cell proliferation, cell death, angiogenesis and metastasis [Amit & Ben-Neriah, 2003; 
Karin, 2006]. 
 
4. Aim of the Study 
The broccoli-derived isothiocyanate SFN is a highly promising chemopreventive 
compound described to interfere with tumor cell growth by inducing cell cycle arrest and 
apoptosis. The underlying molecular mechanisms of cell cycle arrest and apoptosis 
induction are only partially analyzed and need to be fully clarified in order to benefit from 
the positive effects of SFN as a chemopreventive-/therapeutic agent. The aim of the 
present study was to further elucidate these mechanisms in cultured human colon cancer 
cells.  
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With respect to cell cycle arrest the literature describes an accumulation of cells in the 
G2/M phase of the cell cycle, but it is still a matter of controversy whether cells are 
arrested in G2 phase or mitosis. In addition, the causative events for this arrest have not 
been identified yet. In order to analyze the specific phase of cell cycle arrest, the mitosis-
specific antibody MPM-2 represented a valuable tool. Also, the comparison of the effect 
of SFN with that of microtubule- and DNA-damaging agents was a useful approach. 
Programmed cell death (apoptosis) can be initiated via the mitochondrial and the death-
receptor pathway. This study focused on investigating which pathway plays a role in 
SFN-induced apoptosis and what the inducing factors are. The problem was approached 
by analyzing critical proteins involved in upstream- and downstream events of both 
pathways like Cytochrome c, Bcl-2 proteins and caspases, as well as by utilizing a 
leukemia cell line stably overexpressing the anti-apoptotic protein Bcl-2, a crucial factor 
in the regulation of mitochondria-dependent apoptosis. 
The transcription factor NF-κB plays a key role in the regulation of cell survival and cell 
death since the expression of many important anti-apoptotic and pro-survival genes 
depends on its activity. SFN is a strong inhibitor of NF-κB activation, but reports about 
the responsible mechanisms are contradictory. This study aimed at shedding more light on 
how and in which step of the signal transduction cascade SFN interferes with the 
activation of NF-κB.  
The cell line utilized in this study, the human colon carcinoma cell line 40-16, is a clone 
of the parental cell line HCT116. A colon cancer cell line was chosen for the 
mechanistical investigations due to the fact that the colon is one of the organs most 
affected by nutrition. In addition, the colon is the only organ in the human body where - 
in addition to the systemic exposure by absorbed SFN - a topological exposure to SFN 
takes place due to the thioglucosidase activity of the colonic microflora. Since 
isothiocyanates underlie a rapid metabolism, and topological exposure in the colon is 
limited due to intestinal transit, the aim of the study was to analyze time-dependency of 
SFN-induced anti-proliferative effects. Thus, the impact of short exposure times (3, 6 and 
12 hours) and the reversibility of G2/M cell cycle arrest and apoptosis induction were 
investigated.  
In broccoli, apart from many other ingredients like fiber, carbohydrates, proteins and 
vitamins, the glucosinolate glucobrassicin - the precursor of DIM - is present in 
considerable amounts next to glucoraphanin, the precursor of SFN. Significant 
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differences exist between SFN and DIM regarding the mechanisms of modulation of drug 
metabolism and cell growth inhibition. Therefore, potential synergistic or antagonistic 
interactions between SFN and DIM in terms of anti-proliferative activity were 
investigated using the method of Chou and Talalay (1984). 
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Manuscript is in preparation for submission to “Molecular Cancer Therapeutics” 
 
In this manuscript the chemopreventive isothiocyanate sulforaphane was shown to induce 
a mitotic cell cycle arrest in the human colon cancer cell line 40-16. This arrest was 
followed by caspase-dependent apoptosis, which was mediated by the mitochondria-
dependent pathway of apoptosis induction. Sulforaphane potently inhibited NF-κB 
activation upstream of its nuclear translocation and decreased the expression of a series of 
anti-apoptotic, NF-κB-dependent genes, which supposedly facilitated apoptosis induction. 
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Transient exposure of 40-16 human colon carcinoma cells to sulforaphane for up to 6 h 
resulted in reversible G2/M cell cycle arrest and cytostatic growth inhibition, whereas a 
minimum continuous exposure time of 12 h was necessary for sulforaphane to 
irreversibly arrest cells in G2/M and subsequently induce apoptosis. Low concentrations 
of sulforaphane caused a transient decrease in cytoplasmic glutathione levels followed by 
glutathione induction after 24 h. However, depletion of glutathione did not seem to play a 
role for sulforaphane-induced apoptosis. 
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Combination effects of sulforaphane (SFN) and 3,3’-diindolylmethane (DIM) were 
investigated in terms of cell growth inhibition in the 40-16 human colon carcinoma cell 
line. SFN and DIM inhibited cell proliferation antagonistically at low concentrations, but 
synergistically at cytotoxic concentrations. A threshold concentration of 10 µM SFN in 
the mixture resulted in strong G2/M cell cycle arrest. 
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Abstract  
Sulforaphane (SFN) is a naturally occurring cancer chemopreventive isothiocyanate found as its 
glucosinolate precursor in cruciferous vegetables like broccoli. Apart from its ability to modulate 
carcinogen metabolism SFN also acts by anti-proliferative and apoptosis-inducing activities. The 
objective of the present study was to elucidate the mechanisms of SFN-induced cell cycle arrest 
and apoptosis induction in molecular terms, using the human colon carcinoma cell line 40-16. 
SFN induced a cell cycle arrest in G2/M phase after 24 h with subsequent apoptosis induction after 
48 h of exposure. SFN treatment led to a significant increase of mitotic cells indicating that SFN 
activated the spindle checkpoint, possibly due to microtubule damage. Subsequent cell death is 
mediated via the mitochondria-dependent apoptosis pathway shown by mitochondrial membrane 
potential disruption, Cytochrome c release and resistance of Bcl-2 overexpressing Jurkat cells 
toward SFN-induced apoptosis. In addition, SFN inhibits NF-κB activation and thereby 
downregulates NF-κB-dependent anti-apoptotic proteins like Bcl-2, XIAP and c-FLIP facilitating 
apoptosis induction. 
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1. Introduction 
The isothiocyanate sulforaphane (SFN) is a well-known, highly promising cancer 
chemopreventive agent. SFN was first identified in 1992 as a principal inducer of phase II 
enzymes including NAD(P)H:quinone oxidoreductase in broccoli (1). Subsequently, numerous 
studies were conducted demonstrating chemopreventive efficacy of SFN. For example, SFN was 
shown to inhibit 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis (2), 
azoxymethane-induced colonic aberrant crypt foci formation in rats (3) and intestinal adenoma 
formation in ApcMin/+ mice (4, 5). Apart from its modulatory effects on carcinogen metabolism, 
current research indicates that inhibition of cell proliferation contributes to the chemopreventive 
activities of SFN (6, 7). In particular, SFN was shown to arrest few cancer cell lines in G1- and the 
majority of cultured cancer cells in G2/M phase of the cell cycle (8-15). With respect to the SFN-
mediated G2/M arrest, Singh et al. proposed that SFN-induced reactive oxygen species (ROS) 
may cause DNA damage in PC-3 human prostate cancer cells and consequently activate the DNA 
damage checkpoint. This was shown to be mediated via phosphorylation of cell division cycle 25 
C (Cdc25C) by checkpoint kinase 2 (16). On the contrary, Jackson and Singletary demonstrated 
that SFN halted human mammary carcinoma cells in early mitosis by disrupting microtubule 
polymerization (17, 18). In the HCT116-derived colon cancer cell line 40-16, we recently 
demonstrated that transient exposure to SFN at a concentration of 15 µM for short incubation 
times up to 6 h caused a reversible G2/M arrest, whereas a minimum continuous exposure time of 
12 h was necessary for SFN to irreversibly arrest cells in G2/M phase and subsequently induced 
apoptosis (Pappa et al., Mol. Nutr. Food Res.). Apoptosis induction in the 40-16 cell line as well 
as its p53 -/- derivative 379.2 was demonstrated by cleavage of PARP [poly(ADP-
ribose)polymerase] (19). As a responsible mechanism the mitochondrial pathway of apoptosis 
induction appeared to be involved as demonstrated by the activation of caspases-7 and -9 as well 
as changes in the protein expression of anti-apoptotic Bcl-xL and pro-apoptotic Bax and Bak 
proteins. Similarly, SFN induced cell death via the mitochondrial pathway in various other cancer 
cell lines (reviewed in (7, 20, 21)).  
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Despite of these numerous investigations, there is still limited understanding on whether the 
mechanisms of SFN-induced cell cycle arrest and apoptosis are causally linked.  
A recent body of evidence indicates that the transcription factor nuclear factor-κB (NF-κB) plays 
a central role in the regulation of cell proliferation, apoptosis and cancer development (22). This 
was of interest for the present investigations since NF-κB was identified as a key target of SFN-
mediated anti-inflammatory mechanisms (23). NF-κB consists of homo- and heterodimeric 
complexes formed from the Rel family of proteins, which consists of five proteins, namely c-Rel, 
Rel A (p65), Rel B, p50 and p52. In quiescent cells the transcription factor is sequestered in the 
cytosol by interaction with the inhibitor protein IκB (inhibitor of NF-κB). Upon exposure of cells 
to stress signals like inflammatory cytokines or oxidative stress, activation and nuclear 
translocation of NF-κB are controlled by rapid phosphorylation, ubiquitination and proteolytic 
degradation of IκB (22). Once in the nucleus, NF-κB dimers bind to consensus DNA elements 
and transactivate transcription of genes encoding numerous different proteins, which are involved 
in a variety of cellular events including tumor cell proliferation, cell death, angiogenesis and 
metastasis (22, 24). The inhibition of NF-κB activation could represent an important mechanism 
contributing to SFN-induced apoptosis induction. Indeed, SFN was shown to inhibit NF-κB 
activation in conjunction with apoptosis induction in the PC-3 human prostate cancer cell line (25, 
26). We sought to investigate this mechanism in the 40-16 colon cancer cell line and to highlight 
important NF-κB-dependent anti-apoptotic factors like Bcl-2 and XIAP that are affected by SFN 
treatment. 
Here, we present novel results on SFN-induced cell cycle arrest and apoptosis induction using the 
human colon cancer cell line 40-16 as a model. Our aim was to elucidate whether both 
mechanisms occurred in parallel, or whether we could detect a cause-consequence relation 
between both. We show that SFN-induced G2/M cell cycle arrest is not a result of DNA damage. 
Instead, the mitotic checkpoint is activated, of which caspase-dependent apoptosis induction is a 
consequence. As apoptotic mechanisms we found the mitochondrial pathway to be involved, 
which is accompanied by caspase-8 activation and the inhibition of NF-κB. 
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2. Materials and Methods 
Cell Culture 
The human colon cancer cell line 40-16, derived from a random HCT116 clone, was kindly 
provided by B. Vogelstein from Johns Hopkins Oncology Center (Baltimore, USA). Cells were 
cultured as described earlier (19). The Jurkat cell line is a human T cell leukemia cell line. Jurkat 
Bcl-2 is a Jurkat cell line overexpressing anti-apoptotic Bcl-2 (27). Jurkat cells were maintained in 
RPMI 1640 medium with 10% fetal bovine serum and penicillin/streptomycin (100 units/ml). 
 
Chemicals 
Sulforaphane (SFN, CAS no. 4478-93-7) was synthesized as described earlier (23). Cell culture 
material was obtained from Invitrogen (Eggenstein, Germany). Fetal bovine serum (FBS) was 
purchased from PAA Laboratories (Pasching, Austria). McCoy’s 5A cell culture medium, 
propidium iodide (PI), RNase A, JC-1, caffeine, methyl methanesulfonate (MMS) and paclitaxel 
were obtained from Sigma-Aldrich (Taufkirchen, Germany). ZVAD-fmk was from Bachem 
(Heidelberg, Germany). All material required for Flow cytometry was purchased from Becton 
Dickinson (Franklin Lakes, NJ USA). Anti-MPM-2 monoclonal antibody (#05-368) was obtained 
from Upstate Biotechnology (Lake Placid, NY USA), and rabbit anti-mouse Alexa Fluor 488 
conjugated secondary antibody (A-11059) was from Molecular Probes (Eugene, Oregon USA). 
NF-κB anti-p65 (sc-109), anti-p50 (sc-1190), anti-Bid (sc-6538) and anti-Bcl-2 (sc-492) 
antibodies were from Santa Cruz (Heidelberg, Germany) and anti-XIAP (610762) and anti-PARP 
(556362) antibodies were from BD Pharmingen (Heidelberg, Germany). Anti-caspase-8 
monoclonal antibody (#9746) was obtained from Cell Signaling Technology (Beverly, USA). 
Anti-caspase-8 monoclonal antibody C15 (mouse IgG2b) recognizes the p18 subunit of caspase-8 
(28). Anti-c-FLIP monoclonal antibody NF6 (mouse IgG1) was described in (29) and recognizes 
both the c-FLIPL and the c-FLIPS isoforms. Anti-β-Actin antibody AC-15 (A5441) was purchased 
from Sigma (Taufkirchen, Germany). Anti-mouse- and anti-rabbit-secondary antibodies were 
obtained from Santa Cruz (Heidelberg, Germany). Jurkat cell lysates as positive- (camptothecin-
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treated) and negative controls for apoptosis were provided by BD Pharmingen (Heidelberg, 
Germany). Materials and equipment for gel electrophoresis were from Bio-Rad (Munich, 
Germany). All other chemicals were from Sigma-Aldrich (Taufkirchen, Germany). 
 
Cell Cycle Analysis 
40-16 cells were plated in 150 mm tissue culture dishes (5 x 104 cells/ml; 35 ml) and treated as 
indicated in Figure legends after overnight growth. Cell cycle analyses were performed as 
described previously (30).  
 
PI exclusion assay 
Cells were plated in 100 mm tissue culture dishes (5 x 104 cells/ml; 10 ml) and treated as 
indicated in Figure legends after overnight growth. Attached and floating cells were collected and 
immediately incubated with cell culture medium containing propidium iodide (2 µg/ml) for 15 
min at RT. DNA staining as an indication for necrotic cells was measured by Flow cytometry. 
 
MPM-2/PI bivariate flow cytometry 
40-16 cells were plated in 150 mm tissue culture dishes as described for cell cycle analysis and 
treated as indicated in the Figure legends after overnight growth. Cells were collected and fixed as 
for cell cycle analysis. After washing twice with PBS containing 0.05% Tween 20 and 2% FBS, 
cells were labeled with MPM-2 antibody (final concentration of 5 µg MPM-2 antibody/ml PBS 
containing 2% FBS) for 1 h at 4 °C. Cells were washed three times with PBS containing 0.05% 
Tween 20 and 1% FBS and incubated with rabbit anti-mouse Alexa Fluor 488 secondary antibody 
(final concentration of 10 µg /ml PBS containing 2% FBS) for 1 h at RT in the dark. After 
washing three times with PBS containing 0.05% Tween 20 and 1% FBS, cells were resuspended 
in 50 µg/ml PI containing 100 µg/ml RNase A and incubated for 30 min at RT in the dark. 
Samples were analyzed using Flow cytometry.  
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NF-κB DNA-binding assay 
Cells were plated in 100 mm tissue culture dishes with 5 x 104 cells/ml; 10 ml and treated as 
indicated in the Figure legends after overnight growth. Cells were scraped into 1 ml of ice cold 
PBS, spun down and resuspended in hypotonic buffer (10 mM sodium phosphate buffer, pH 7.0, 
containing 10 mM NaF, 5 mM MgCl2, 1 mM EDTA, 1 mM PMSF and 1% NP-40), followed by a 
30 min incubation on ice. After centrifugation supernatants were collected representing the 
cytosolic fraction. Nuclei were lysed with hypertonic buffer (hypotonic buffer + 0.5 mM NaCl). 
After centrifugation the supernatant was collected, which represented the nuclear fraction. To 
analyze NF-κB DNA-binding, the “TransAM” NF-κB family kit from ActiveMotif (Rixensart, 
Belgium) was used. The assay was performed according to the manufacturer’s instructions. 
Absorbance readings were normalized to the protein content of each sample determined using the 
bicinchoninic acid (BCA) method (31).  
 
Preparation of mitochondrial extracts 
Cells were plated in 100 mm tissue culture dishes with 5 x 104 cells/ml; 10 ml and treated as 
indicated in the Figure legends after overnight growth. Floating and adherent cells were collected 
and washed once with PBS. The separation of cellular mitochondrial and cytosolic fractions was 
performed with the “ApoAlert Cell fractionation Kit” (Clontech Laboratories Inc., Palo Alto, CA, 
USA) according to the manufacturer’s instructions. 
 
Western Blot Analysis 
For the preparation of whole cell lysates cells were plated in 100 mm tissue culture dishes (5 x 104 
cells/ml; 10 ml) and treated as indicated in the Figure legends after overnight growth. Preparation 
of cell lysates, SDS PAGE and electroblotting was performed as described previously (30). For 
quantitation of protein expression, band densities were semi-quantitatively measured using TINA 
software version 2.09a (Raytest Isotopenmessgeräte GmbH, Staubenhardt, Germany). 
Background staining was subtracted, values were normalized to β
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in relation to control values, which were set as 1.0 for each time point or subcellular fraction, 
respectively. 
 
Measurement of Mitochondrial Membrane Potential 
Mitochondrial membrane potential (∆Ψm) was measured using the dye JC-1 (5,5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethyl-benzimidazolylcarbocyanine iodide). Briefly, cells were plated in 
100 mm tissue culture dishes (5 × 104 cells/ml; 10 ml) and treated as indicated in the Figure 
legends after overnight growth. Cells were incubated with medium containing JC-1 (2.5 µg/ml, 
diluted 1:1000 from stock prepared in DMSO) for 30 min at 37 °C. Cells were washed with PBS 
and analyzed unsing a FACS Calibur Flow cytometer. Loss of ∆Ψm was quantified by quadrant 
analysis with the lower right quadrant representing cells with disrupted membrane potential (loss 
of red fluorescence).  
 
Statistical Analysis 
Results are presented as mean ± standard deviation. For statistical evaluation one-way ANOVA 
analysis and Bonferroni multiple comparison test were applied. Values of p < 0.01 were 
considered as statistically significant.  
 
3. Results 
Dose-dependent effects of SFN on the cell cycle 
SFN is known to have anti-proliferative and apoptosis-inducing activity (21). We have 
demonstrated previously that 40-16 cells are arrested in the G2/M phase of the cell cycle upon 
treatment with SFN [Pappa et al., Mol. Nutr. Food Res.]. Although 6 h of incubation with SFN 
already led to a significant G2/M arrest and cytostatic cell growth inhibition, incubation for 12 h 
and longer was necessary to irreversibly halt the cell cycle in G2/M and to induce apoptosis. To 
further clarify the mechanisms of action, we first investigated the dose-dependency of cell cycle 
effects induced by SFN after 24 h as well as 48 h of treatment. As indicated in Fig. 1A, treatment 
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of 40-16 cells for 24 h and 48 h led to interesting effects on cell cycle progression, which did not 
follow a strict dose-response pattern. After 24 h, the sub-G1 fraction representing apoptotic cells 
increased dose-dependently reaching the highest value at a concentration of 15 µM of SFN. In 
parallel, the percentage of cells in G2/M phase was increased dose-dependently and the maximum 
was observed for 15 µM of SFN, indicating a marked G2/M arrest. G0/G1 and S phase cells were 
concomitantly reduced. A further increase in the SFN concentration to 25 and 50 µM surprisingly 
led to a reversal of the effects observed with lower concentrations: The fraction of cells in sub-G1 
declined, G1- and S-phase increased, and the G2/M peak was reduced almost to control levels.   
After 48 h, results for sub-G1 phase were even stronger compared to 24 h of treatment. SFN 
potently induced apoptosis dose-dependently up to 15 µM (Fig. 1A). Again, higher concentrations 
of SFN were less effective in inducing apoptotic cell death. G0/G1 and S phase were both 
reciprocally regulated in relation to sub-G1, whereas the G2/M fraction showed a slight dose-
dependent increase. Thus, the occurrence of a G2/M cell cycle arrest and subsequent apoptosis 
induction after cell treatment with SFN depends on a relatively narrow concentration window, 
which is around 15 µM in the 40-16 cell line. Increasing or decreasing the concentration leads to 
less pronounced responses. Interestingly, the G2/M arrest appears to directly correlate with cell 
death, since both phenomena are strongest after treatment with 15 µM, the first after 24 h, and the 
latter after 48 h.  
Since the effects seen with a SFN concentration of 50 µM were quite unexpected, we next 
investigated why high concentrations of SFN had relatively little effects on cell cycle distribution 
and apoptosis induction. Since the number of cells was nevertheless dramatically diminished after 
treatment, we hypothesized that necrosis could be induced. Therefore we analyzed necrosis 
induction by positive PI staining and subsequent Flow cytometry analysis. As shown in Fig. 1B, 
SFN at the concentration of 15 µM marginally induced necrosis after 48 h, whereas at 50 µM, the 
percentage of necrotic cells was significantly induced after 24 h and especially after 48 h of 
treatment. These data indicate that in the 40-16 cell line high concentrations of SFN induce 
necrosis, whereas concentrations around 15 µM induce a cell cycle arrest in G2/M phase, followed 
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by apoptosis induction after 48 h. As these effects were strongest for the concentration of 15 µM 
we used this concentration for the following experiments.   
 
SFN-induced G2/M arrest is not abrogated by caffeine 
Next we aimed to shed more light onto the mechanism of G2/M arrest induction by SFN. Cell 
cycle arrest in G2/M phase could be the result of two main causes: i) DNA damage during G2 
leading to the activation of the DNA damage checkpoint and halt of the cell cycle before mitosis 
entry, or ii) spindle perturbation in early mitosis, for instance due to tubulin hyperpolymerization. 
It is not possible to distinguish between those two mechanisms using cell cycle analysis. 
Therefore we used caffeine which is well-known for its ability to abrogate the DNA damage 
checkpoint (32, 33). As positive control for DNA damage induction we used the alkylating agent 
methyl methanesulfonate (MMS). Results of cell cycle analysis are depicted in Fig. 2. Single 
treatments using SFN and MMS both induced a significant G2/M arrest, whereas caffeine induced 
a weak accumulation of cells in G0/G1. The combination of SFN and caffeine further enhanced the 
G2/M fraction. In contrast, MMS plus caffeine led to a significant attenuation of the G2 arrest. It is 
evident that caffeine is able to abrogate MMS-induced, but not SFN-induced G2/M cell cycle 
arrest.   
These results suggest that SFN does not induce DNA damage and does not activate the DNA 
damage checkpoint in the 40-16 cell line. 
 
SFN induces accumulation of cells in mitosis 
To clarify if SFN-induced G2/M arrest was due to an accumulation of cells in mitosis, we utilized 
the mitosis-specific monoclonal antibody MPM-2. This antibody binds to phospho-epitopes that 
are phosphorylated only during mitosis on many mitotic proteins (34). As a positive control for 
mitotic spindle disruption we treated 40-16 cells with the microtubule-interfering agent paclitaxel. 
Cell cycle analyses shown in Fig. 3 revealed that both SFN and paclitaxel strongly induced a 
G2/M arrest. Both paclitaxel and SFN increased the number of mitotic cells about 10-fold. Thus, 
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SFN appears to act as a microtubule-interfering agent which activates the spindle checkpoint 
leading to an arrest of cells in mitosis.  
 
SFN inhibits the expression of NF-κB dependent anti-apoptotic genes 
We have shown previously that SFN inhibits the lipopolysaccharide-induced activation of pro-
inflammatory genes through inhibition of NF-κB DNA binding in murine macrophages (23). Due 
to its important role in the induction of anti-apoptotic genes, we were interested in whether SFN 
might inhibit NF-κB-dependent effects also in the 40-16 cell line. We quantified binding of each 
of the five NF-κB subunits in the nuclear extracts of treated cells to the corresponding consensus 
sequences using an Elisa-based method. As a positive control for NF-κB activation we treated the 
cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) for 1 h. 
As the signal intensity for the subunits Rel B and p52 was very low, we assume that they are not 
expressed in the 40-16 cell line. Results for the subunits p50, p65 and c-Rel are depicted in Fig. 
4A. Treatment of cells with 15 µM SFN for 3 h inhibited the activation of NF-κB as measured via 
binding of the p50 chain of NF-κB to the consensus sequence by ~60%. TPA as a positive control 
significantly enhanced p50-DNA binding about 3-fold. When cells were pretreated with SFN for 
2 h prior to the addition of TPA for an additional hour, DNA-binding of p50-NF-κB was reduced 
to control levels. The results were similar for p65-NF-κB, although the overall signal intensity 
was weaker compared to p50, either due to lower expression or inefficient nuclear translocation. 
In the case of c-Rel values were very low, regardless of the treatment regime. Thus, c-Rel does 
not appear to play a role in NF-κB dimerization in the 40-16 cell line. Notably, the endogenous 
background NF-κB activity observed in the control cells can be efficiently blocked via SFN 
treatment of the cells. 
In order to determine whether SFN inhibits the translocation of NF-κB into the nucleus we 
performed Western blotting with nuclear and cytosolic extracts of cells treated with SFN, TPA or 
the combination thereof. As shown in Fig. 4B, TPA induced the translocation of both p50 and p65 
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into the nucleus, whereas SFN and SFN plus TPA did not. In summary, we show that SFN 
inhibits the nuclear translocation of NF-κB and thereby inhibits NF-κB activation. 
The transcription factor NF-κB is involved in the regulation of numerous cellular proteins 
including many anti-apoptotic and pro-survival factors (22). Therefore we addressed the question 
whether apoptosis induction upon SFN treatment is facilitated by the downregulation of NF-κB-
dependent proteins involved in apoptosis regulation.  
We investigated protein levels of Bcl-2, the X-linked mammalian inhibitor of apoptosis protein 
(XIAP), as well as of c-FLIP using immunoblotting (Fig. 4C). Bcl-2 is an anti-apoptotic member 
of the Bcl-2 family of proteins, the major regulators of the mitochondrial pathway of apoptosis 
(35). XIAP belongs to the family of inhibitors of apoptosis proteins (IAPs), endogenous caspase 
inhibitors (36). XIAP selectively inhibits the mitochondrial pathway of apoptosis via binding to 
caspases-3, -7 and -9 (36). C-FLIP, also described to be NF-κB-dependent, is an anti-apoptotic 
protein acting at the death-inducing signaling complex (DISC), where it prevents caspase-8 
activation (37). As can be seen in Fig. 4C, SFN markedly downregulated XIAP, Bcl-2 as well as 
c-FLIP after 24 h and especially after 48 h. In a previous study we showed that SFN leads to a 
down-regulation of Bcl-xL, another anti-apoptotic member of the Bcl-2 protein family (19).  
In summary, we conclude that SFN potently inhibits NF-κB activation, which results in decreased 
expression levels of the anti-apoptotic proteins Bcl-2, XIAP and c-FLIP. 
 
SFN causes disruption of the Mitochondrial Membrane Potential and Cytochrome c release 
The mitochondria play a central role in apoptosis induction (35). Disruption of the Mitochondrial 
Membrane Potential is an irreversible trigger of the mitochondrial cell death cascade leading to 
Cytochrome c release from the intermembrane space of the mitochondria into the cytosol, the 
activation of initiator caspase-9 and subsequent activation of the effector caspases-3, -6 and -7. As 
a result of caspase activation a number of cellular substrates including DNA is cleaved, resulting 
in apoptotic cell death (35). We have previously shown that SFN treatment led to an increased 
ratio of pro-apoptotic Bax and Bak proteins in relation to anti-apoptotic Bcl-xL protein expression 
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and the activation of caspase-9 (19). After semi-quantitative analysis of Bcl-2 protein expression 
(compare Fig. 4C), and comparison with protein expression data of Bax and Bak from our 
previous work (19), expression ratios between these proteins were calculated. After 24 h Bax:Bcl-
2 and Bak:Bcl-2 ratios were ~0.5 and 1.0, respectively, whereas after 48 h the expression ratio for 
both pro-apoptotic proteins in relation to Bcl-2 was ~2.0 (data not shown). These results indicate 
that at the later time point protein expression of Bcl-2 family proteins is in favor of the pro-
apoptotic members Bax and Bak, which is consistent with the marked increase of the apoptotic 
fraction after 48 h as presented in Fig. 1A.  
Next we sought to determine mitochondrial membrane depolarization and release of Cytochrome 
c from the intermembrane space into the cytosol. Fig. 5A depicts representative dot plots of cells 
stained with JC-1 and Fig. 5B gives a summary of results obtained after 6 h, 12 h, 24 h and 48 h 
of incubation with SFN. The percentage of cells with disrupted Mitochondrial Membrane 
Potential was significantly augmented already after 6 h of SFN treatment (5.3% vs. 2.3% in the 
control). Time-dependently the fraction of cells with depolarized mitochondrial membrane 
increased, reaching ∼35% after 48 h. Usually the opening of the outer mitochondrial membrane is 
accompanied by the release of Cytochrome c into the cytosol. To test whether this took place in 
40-16 cells as well, mitochondrial and cytosolic fractions were prepared and protein levels of 
Cytochrome c were visualized by immunoblotting. Proper separation of mitochondrial and 
cytosolic extracts was assured by probing for the mitochondria-specific Cytochrome Oxidase 
subunit 4 (COX4). As shown in Fig. 5C, treatment with SFN caused an increase of Cytochrome c 
in the cytosolic fraction after 24 h and more pronounced after 48 h, while the amount of 
Cytochrome c in the mitochondrial fraction was slightly decreased. Collectively, these results 
indicate that SFN potently induces the mitochondrial, intrinsic pathway of apoptosis in the 40-16 
cell line. 
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Apoptosis feedback mechanisms are also induced by SFN treatment: caspase-8 activation and Bid 
cleavage 
In addition to the mitochondrial pathway of apoptosis induction also an extrinsic, death receptor-
mediated pathway has been described (38-40). Death-receptor-mediated apoptosis is normally 
induced via extracellular death ligand stimuli, but recent literature suggests that death-receptor-
associated events can also be induced as a feedback mechanism of the activation of downstream 
effector caspases like caspases-3 and -7 (41). Since we have shown that SFN triggers the 
instrinsic apoptosis signaling we aimed to address the question whether these feedback 
mechanisms might also be affected by SFN treatment. 
Thus, we incubated 40-16 cells with SFN for 24 or 48 h and analyzed the processing of 
procaspase-8. As visualized in Fig. 6, SFN induced the processing of procaspase-8 to the p43/p41 
cleavage products and to the catalytically active subunit p18 (caspase-8), presumably facilitated 
by down-regulation of NF-κB-dependent c-FLIP. SFN-induced caspase-8 activation was 
completely blocked by the pan-caspase inhibitor zVAD-fmk.  
Bid belongs to the pro-apoptotic members of the Bcl-2 protein family and represents a link 
between death receptor- and mitochondria-mediated apoptosis. As a substrate for caspase-8, Bid 
is cleaved into truncated Bid (tBid), which then translocates into the mitochondria to facilitate the 
permeabilization of the outer mitochondrial membrane (35). In a Western blot we visualized the 
levels of full-length Bid that were reduced after 24 h and 48 h of SFN treatment, probably due to 
caspase-8-mediated cleavage (Fig. 6). Cotreatment of cells with SFN and zVAD-fmk partly 
blocked this cleavage. In summary, SFN-induced caspase-8 activation is a feedback mechanism 
which in turn leads to cleavage of Bid into tBid. As a control and hallmark for apoptosis induction 
we analyzed poly(ADP-ribose)polymerase (PARP) cleavage. Also shown in Fig. 6, SFN induced 
the cleavage of PARP in 40-16 cells after 24 h and 48 h, which was inhibited by co-incubation 
with the caspase inhibitor zVAD-fmk. Thus, SFN-induced apoptosis is entirely dependent on 
caspases.  
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Chronology of events induced by SFN 
SFN was shown to induce a cell cycle arrest in mitosis after 24 h as well as apoptosis via the 
mitochondria-dependent pathway after 48 h of treatment. Yet the detailed interplay between these 
two events is unclarified. Therefore we investigated if SFN-induced apoptosis is a secondary 
event after the cell cycle arrest in mitosis or if both signaling pathways are initiated in parallel.  
We treated 40-16 cells with SFN alone or in combination with zVAD-fmk for 48 h and analyzed 
cell cycle distribution. We observed that zVAD-fmk potently abrogated the increase of sub-G1 
fraction seen with SFN alone (Fig. 7). In contrast, the G2/M arrest observed with SFN incubation 
was unaltered by cotreatment with zVAD-fmk. Hence, it is likely that the mitosis arrest precedes 
apoptosis induction in 40-16 colon carcinoma cells.  
To analyze if the chronology of events is not only limited to a single cell line, we also used Jurkat 
cells for additional analysis. Since the Jurkat cells were more sensitive toward SFN, we used 10 
µM instead of 15 µM for treatment. In wildtype (wt) Jurkat control cells apoptosis was also 
induced after 48 h of treatment with SFN (Fig. 8A, left panels). Apoptosis could be blocked using 
the pan-caspase inhibitor zVAD-fmk, whereas the mitosis arrest was still evident. To unravel 
whether apoptosis in Jurkat cells after SFN treatment is also induced via mitochondria-dependent 
signaling, Jurkat cells over-expressing anti-apoptotic Bcl-2 protein were utilized (Fig. 8A, right 
panels). Upon treatment of Jurkat Bcl-2 cells with SFN for 48 h no apoptosis induction was 
detected, but the mitosis arrest was still present. These data suggest that apoptosis induction by 
SFN is a secondary event following mitosis arrest. 
To assure that the chronology of events is indeed true, we investigated PARP cleavage as well as 
the activation of caspase-8 in Bcl-2- and wt control Jurkat cells. Again we also tested the effect of 
the caspase inhibitor zVAD-fmk. As a positive control for apoptosis we used a camptothecin-
treated Jurkat cell lysate. In Jurkat wt cells SFN induced PARP cleavage as well as caspase-8 
activation, which was both blocked by co-treatment with zVAD-fmk (Fig. 8B). In contrast, Jurkat 
Bcl-2 cells were completely resistant toward apoptosis induction and caspase-8 activation by 
SFN.  
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Collectively these data show that not only in 40-16 cells, but also in Jurkat cells the chronology of 
events induced by SFN is the same. SFN induces a mitosis arrest that precedes mitochondria-
dependent apoptosis induction. 
 
4. Discussion 
SFN is known for its anticancer-activities including the induction of cell cycle arrest and 
apoptosis in tumor cells (21). Despite intense research on this field the mechanisms underlying 
SFN’s anti-proliferative effects are still a matter of controversy. In the present study we provide 
evidence that SFN acts as an anti-mitotic agent in the human colon cancer cell line 40-16, shown 
by two approaches. 1) Caffeine, able to abrogate DNA-damage induced cell cycle arrest in G2, 
blocked alkylating agent MMS-induced, but not SFN-induced G2/M cell cycle arrest. 2) SFN 
treatment led to the accumulation of cells in mitosis, similar to microtubule-damaging paclitaxel, 
shown by the binding intensity of the mitosis-specific antibody MPM-2. Moreover, we 
demonstrate that apoptosis induction is a consequence of the mitotic arrest, since the pan-caspase 
inhibitor zVAD-fmk blocked SFN-induced apoptosis, but not the mitotic arrest. This notion is 
supported by the kinetics of events induced by SFN, being a marked cell cycle arrest after 24 h 
followed by apoptosis after 48 h. With regard to the mechanism of apoptotic cell death initiation 
we demonstrate here, that apoptosis is initiated via the mitochondrial pathway leading to the 
disruption of the mitochondrial membrane potential and Cytochrome c release into the cytosol. 
Furthermore, Bcl-2 overexpressing Jurkat cells were completely resistant toward SFN-induced 
apoptosis, but not toward the mitotic arrest. Thus, M phase arrest as the primary effect of SFN 
treatment is not unique for the 40-16 cell line. Others have also reported about spindle 
perturbations upon SFN treatment: Jackson and Singletary demonstrated a cell cycle arrest in 
early mitosis and aberrant mitotic spindles, accompanied by elevated p34cdc2 (cdc2) kinase 
activity upon treatment of the BALB/c mouse mammary carcinoma cell line F3II with 15 µM 
SFN (17). The authors also reported that SFN inhibited tubulin polymerization in vitro, but at 
non-physiologically high doses. Similar results were shown for MCF-7 human mammary 
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carcinoma cells, in which cyclin B1, the cyclin responsible for the G2-M transition together with 
cdc-2 kinase, was elevated by SFN treatment, indicating that cells had entered mitosis (18). 
Mitotic spindle disruption was also described to occur in the human bladder cancer cell line UM-
UC-3 upon incubation with a broccoli sprout extract (containing mainly SFN) (42). In that study, 
apoptosis induction was mitochondria-mediated and evident only at later time points (48 h) 
compared with the mitotic arrest, that was strongest after 24 h of treatment. Thus, the behaviour of  
UM-UC-3 cells resembles that of 40-16 cells as presented in this study. Pham et al. showed SFN-
induced mitotic arrest to be accompanied with an increase in mitotic marker phospho-histone H3 
and cyclin B1 in human pancreatic adenocarcinoma cells (39). Interestingly, consistent with our 
results, G2/M phase arrest could not be blocked by the checkpoint kinase 1 (Chk 1) inhibitor 
UCN-01, which is able to override the DNA damage checkpoint similar to caffeine, whereas γ-
radiation-induced G2 arrest was blocked by UCN-01. Still the authors detected apoptosis only 
after treatment with higher concentrations of SFN and indepenent of the G2/M phase arrest which 
is in contrast to the present report. 
Mechanisms responsible for SFN-induced spindle perturbation still need to be explored. However, 
one can speculate that SFN’s thiol-reactivity could play a decisive role, since tubulin contains 
many cysteine residues (43). It is known that the accessible thiol groups of tubulin are very 
sensitive toward oxidation and that oxidation or binding to these residues leads to the inhibition of 
tubulin polymerization (44).   
Importantly, SFN was shown to induce DNA damage and subsequent cell cycle arrest in G2 in 
other cultured cell lines. Singh et al. demonstrated reactive oxygen species (ROS)-induced 
double-strand breaks of the DNA to be the trigger for an accumulation of PC-3 human prostate 
cancer cells in G2 phase upon treatment with SFN (16). In another study SFN-induced ROS 
formation was also associated with G2/M cell cycle arrest (11). We investigated cellular GSH 
levels as well as the formation of ROS in the 40-16 cell line [Pappa et al., Mol. Nutr. Food Res.]. 
We could not detect any significant enhancement of ROS after treatment with SFN for several 
time points. In addition, SFN-induced transient GSH depletion was not associated with sustained 
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G2/M cell cycle arrest and apoptosis. Thus, SFN is able to activate distinct signaling cascades, one 
involving spindle disruption and mitotic arrest, the other involving ROS formation and the 
activation of the DNA damage checkpoint. Whether one or the other outcome occurs, most likely            
depends on the genetic background of the cells treated with SFN, mainly in terms of cell cycle 
checkpoint functionality. Interestingly, in a very recent report the induction of autophagy has been 
described as a defense mechanism against apoptosis and supposedly the reason for the delayed 
cell death upon treatment with SFN (45).  
In the present study, SFN-induced mitotic arrest was followed by mitochondria-dependent cell 
death shown by disruption of ∆Ψm, Cytochrome c release into the cytosol and apoptosis-
resistance of Bcl-2 overexpressing cells. However, caspase-8 – a caspase mainly involved in death 
receptor-mediated apoptosis – was also activated by SFN treatment which we assumed to be a 
feedback mechanism of the activation of downstream effector caspases like caspases-3 and -7. In 
other studies SFN-induced apoptosis was caspase-8-dependent, suggestive of a more important 
role for this protease (11, 38). Death receptor-induced apoptosis has also been described to be 
induced by SFN. In MDA-MB-231 breast cancer cells activation of apoptosis by SFN seemed to 
be initiated through induction of Fas ligand (46). An enhancement of Tumor necrosis factor-
related apoptosis-inducing ligand (TRAIL)-induced apoptosis by SFN was reported to involve 
upregulation of  death receptor 5 (DR5), a receptor for TRAIL (47, 48). On the other hand, the 
majority of reports demonstrate mitochondria-mediated cell death by SFN (reviewed in (21)).  
The molecular mechanisms involved in cell death after prolonged mitotic checkpoint activation 
have not been defined so far (49). Microtubule-damage is often associated with Bcl-2 
phosphorylation which is considered to inactivate anti-apoptotic properties of Bcl-2 (50, 51). This 
could lower the threshold for apoptosis induction. Another possible mechanism could involve 
direct interaction of mitochondria-bound tubulin with Bcl-2 proteins and the induction of 
apoptosis upon treatment with anti-mitotic drugs (52).  
We show here that SFN is a strong inhibitor of NF-κB activation in 40-16 cells acting upstream of 
the translocation of NF-κB into the nucleus, which is consistent with the current literature. Xu et 
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al. proposed SFN-mediated NF-κB inhibition to be due to a reduction of IKK phosphorylation, 
particularly IKKβ in PC-3 human prostate cancer cells (25). Consequently, IκBα phosphorylation 
and degradation was inhibited. Of note, in murine Raw 264.7 macrophages SFN did not inhibit 
the nuclear translocation of NF-κB but blocked NF-κB DNA binding in the nucleus (23). Thus, 
different mechanisms of action seem to exist which could involve redox- and thiol-mediated 
interactions of SFN with NF-κB subunits or with further upstream targets of NF-κB signaling like 
IKK or IκB.  
NF-κB regulates the expression of a variety of survival and anti-apoptotic genes. We investigated 
protein levels of important NF-κB dependent apoptosis-related factors and found Bcl-2, XIAP and 
c-FLIP to be downregulated upon SFN treatment. It remains unclear whether NF-κB inhibition is 
essential for SFN-induced apoptosis induction, but it definitely contributes to facilitate cell death 
upon cell damage. Taking the NF-κB dependent, anti-apoptotic protein Bcl-2 as an example, 
downregulation of Bcl-2 is accompanied by apoptosis induction and Bcl-2 overexpression 
prevents cell death. 
Taken together, we have comprehensively demonstrated that the isothiocyanate SFN exerts its 
anti-proliferative activity by mechanisms involving mitotic spindle perturbation and subsequent 
apoptosis induction in 40-16 human colon carcinoma cells. Cell death was clearly mediated via 
the mitochondria-dependent pathway of apoptosis. These results contribute to a better 
understanding of the molecular mechanisms responsible for SFN’s anticancer potential with 
regard to cell cycle arrest and apoptosis induction. Knowledge of these mechanisms is crucial for 
a further development of this highly promising compound into a widely used cancerpreventive-
/therapeutic agent.  
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Figure legends: 
 
Figure 1. (A) Dose-dependent effects of SFN on the cell cycle. 40-16 cells were treated with 
0.5% DMSO as a solvent control (c) or with SFN at the indicated concentrations in µM for 24 h 
or 48 h. Cell cycle analyses of fixed cells were performed by Flow cytometry after staining DNA 
with PI. Bars represent the percentage of cells in the cell cycle phases sub-G1, G0/G1, S and G2/M. 
Data are means ± SD of at least three independent experiments. * Significantly (p < 0.01) 
different from respective control. 
 (B) PI exclusion for necrosis detection. 40-16 cells were treated with 0.5% DMSO as solvent 
control (c) or with SFN at the concentrations of 15 µM (S 15) or 50 µM (S 50) for 24 h (black 
bars) or 48 h (white bars). Percentages of PI positive cells represent those that have undergone 
necrotic cell death. Data are means ± SD of three independent experiments. * Significantly (p < 
0.01) different from respective control. 
 
Figure 2. Effects of caffeine on G2/M cell cycle arrest. 40-16 cells were treated with 0.2% DMSO 
as solvent control, SFN (15 µM), MMS (250 µM), caffeine (1.5 mM), the combination of SFN + 
caffeine or the combination of MMS + caffeine for 24 h. Cell cycle analyses of fixed cells were 
performed by Flow cytometry after staining DNA with PI. Upper panel: representative histograms 
of cell cycle distribution. Lower panel: means and SD of percentages of cell cycle distribution. 
Data are from three independent experiments. a Significantly (p < 0.01) different from respective 
control. b Significantly (p < 0.01) different from the respective treatment without caffeine within 
the same cell cycle phase. 
 
Figure 3. Determination of mitotic cells. 40-16 cells were treated with 0.2% DMSO as solvent 
control, SFN (15 µM) or paclitaxel (0.1 µM) for 24 h. Fixed cells were probed with mitosis-
specific MPM-2 monoclonal antibody followed by an Alexa Fluor 488-conjugated secondary 
antibody, staining of DNA with PI and Flow cytometry analysis. Left panel: representative dot 
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plots for discrimination of mitotic cells (MPM-2 positive cells with 2n DNA content) with mean 
percentages of mitotic cells ± SD from five independent experiments. Right panel: respresentative 
histograms of cell cycle distribution with mean percentages of cells in G2/M phase ± SD from five 
independent experiments. * Significantly (p < 0.01) different from respective control. 
 
Figure 4. SFN inhibits NF-κB activation and the expression of NF-κB-dependent proteins. (A) 
Transactivation of NF-κB subunits p50, p65 and c-Rel. 40-16 cells were treated with 0.2% DMSO 
as solvent control for 3 h (black bars), SFN at a concentration of 15 µM for 3 h (white bars), TPA 
at a concentration of 0.15 µM for 1 h (dark grey bars) or with SFN (15 µM) for 2 h before the 
addtion of TPA (0.15 µM) and incubation for another hour (light grey bars). Binding of activated 
NF-κB subunits present in the nuclear extracts of treated 40-16 cells to the NF-κB consensus 
sequence was quantified with specific antibodies against p50, p65 and c-Rel and colorimetric 
visualisation. Absorbance readings were normalized to protein concentrations. Data are means ± 
SD of three independent experiments. * Significantly (p < 0.01) different from control. # 
Significantly (p < 0.01) different from TPA treatment.  (B) Nuclear translocation of NF-κB. 
Immunoblotting for NF-κB p65 and p50 was performed using cytosolic and nuclear extracts of 
40-16 cells treated with 0.2% DMSO for 3 h, SFN (S; 15 µM) for 3 h, TPA (T; 0.15 µM) for 1 h 
or SFN for 2 h + TPA for 1 h. Equal loading was confirmed by using an anti-β-actin antibody. (C) 
Immunoblotting for XIAP, Bcl-2 and c-FLIP using whole cellular lysates of 40-16 cells treated 
with 0.2% DMSO as control or SFN (15 µM) for 24 h or 48 h. Equal loading was confirmed by 
using an anti-β-actin antibody.  
 
Figure 5. SFN induces mitochondrial membrane permeabilisation and release of Cytochrome c 
into the cytosol. (A) Representative Flow histograms depicting JC-1 fluorescence in 40-16 cells 
treated with 0.2% DMSO (control) or SFN (15 µM) for 48 h. Cells with disrupted ∆Ψm are 
located in the lower right quadrant. (B) Percentages of  cells with disrupted ∆Ψm in 40-16 cells 
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treated with 0.2% DMSO as control (black bars) or SFN at a concentration of 15 µM (white bars) 
for 6 h, 12 h, 24 h or 48 h. Data are means ± SD of five independent experiments. * Significantly 
(p < 0.01) different from respective control. (C) Immunoblotting for Cytochrome c (Cyt c) using 
cytosolic (cyto) and mitochondrial (mito) fractions of 40-16 cells treated with 0.2% DMSO (c) or 
SFN (15 µM) for 24 h or 48 h. Efficient separation of cytosolic and mitochondrial cell fractions 
was confirmed by using an anti-COX4 antibody. Equal loading was confirmed by using an anti-β-
actin antibody. 
 
Figure 6. SFN induces activation of caspase-8, Bid cleavage and caspase-dependent apoptosis. 
Immunoblotting for procaspase-8 and activated caspase-8, Bid and PARP was performed with 
lysates from 40-16 cells treated with 0.5% DMSO as control, SFN (15 µM), zVAD-fmk (zV; 20 
µM) or the combination of SFN + zVAD-fmk (S+zV) for 24 h or 48 h. Caspase-8 activation was 
investigated using an antibody directed against procaspase-8 (55/53 kDa and 43/41 kDa) and the 
catalytically active subunit of caspase-8 (18 kDa). PARP cleavage was investigated using an 
antibody directed against full length PARP (uncl. PARP; 116 kDa) and the cleavage product (cl. 
PARP; 89 kDa). Equal loading was confirmed by using an anti-β-actin antibody. 
 
Figure 7. Cell cycle analyses of 40-16 cells treated with 0.5% DMSO as solvent control, SFN (15 
µM) or SFN (15 µM) + zVAD-fmk (20 µM) for 48 h. Representative Flow histograms are 
depicted with percentages for each cell cycle phase in the upper right corner. Data are means ± SD 
of three independent experiments. a Significantly (p < 0.01) different from control. b Significantly 
(p < 0.01) different from SFN treatment.  c Significantly (p < 0.01) different from control and SFN 
treatment. 
 
Figure 8. Effects of SFN on Jurkat cells. (A) Cell cycle analysis of wildtype (wt) or Bcl-2- (Bcl-
2) transfected Jurkat cells treated with 0.5% DMSO as solvent control, SFN (10 µM) or SFN (10 
µM) + zVAD-fmk (20 µM) for 48 h. Representative Flow histograms are depicted with 
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percentages for each cell cycle phase in the upper right corner. Data are means of two independent 
experiments. (B) Immunoblotting for PARP and procaspase-8 was performed with lysates from 
Jurkat wt and Jurkat Bcl-2 cells treated with 0.5% DMSO as control, SFN (10 µM) or the 
combination of SFN (10 µM) + zVAD-fmk (20 µM; S+zV) for 48 h. Additionally, negative (nc) 
and positive (pc) control lysates were analyzed. Caspase-8 activation was investigated using an 
antibody directed against procaspase-8 (Pro-C8; 55/53 kDa and 43/41 kDa). PARP cleavage was 
investigated using an antibody directed against full length PARP (uncl. PARP; 116 kDa) and the 
cleavage product (cl. PARP; 89 kDa). Equal loading was confirmed by using an anti-β-actin 
antibody. 
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Fig. 1 
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
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Fig. 7 
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Abstract  
Sulforaphane (SFN), a cancer chemopreventive compound derived from broccoli, is able to 
induce cell cycle arrest and apoptosis in various tumor cell lines. Here we show that cell growth 
inhibition by SFN follows a biphasic pattern: Transient exposure of 40-16 human colon 
carcinoma cells for up to 6 h resulted in reversible G2/M cell cycle arrest and cytostatic growth 
inhibition even at elevated concentrations, whereas a minimum continuous exposure time of 12 h 
was necessary for SFN to irreversibly arrest cells in G2/M phase and subsequently induce 
apoptosis. IC50 values after 12 h of exposure followed by drug-free recovery up to 72 h (6.4 – 8.1 
µM) were indistinguishable from those of chronic exposure for 24 h to 72 h (5.4 – 6.6 µM). Low 
concentrations of SFN caused a transient decrease in glutathione (GSH) levels followed by GSH 
induction, which may be related to reversible G2/M arrest and cytostatic effects. Depletion of 
GSH does not seem to play a role in SFN-mediated apoptosis induction. Our data clearly 
contribute to a better understanding of the kinetics of anti-proliferative activity of SFN. 
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Introduction 
Colorectal cancer is the second leading cause of cancer-related deaths in industrialized countries 
[1]. Strong evidence exists from epidemiological studies that high intake of cruciferous vegetables 
is associated with a lower risk of developing this disease [2, 3]. Cancer preventive potential of 
cruciferous vegetables such as broccoli has been attributed to their content of glucosinolates. 
Through catalytic mediation of myrosinase (β-thioglucosidase), which is released upon physical 
damage of plant cells (e.g. during cutting or chewing), glucosinolates are hydrolyzed, releasing 
the corresponding isothiocyanates (ITCs) [4]. ITCs are reactive Michael acceptor type-compounds 
which rapidly bind to thiol groups, leading to dithiocarbamate formation [5]. Intracellularly, ITCs 
are conjugated to the tripeptide glutathione (GSH), the most abundant thiol present in the 
cytoplasm. This generally leads to a transient depletion of GSH, which in turn activates the 
transcription of γ-glutamylcysteine synthetase (γ-GCS), the key regulatory enzyme in glutathione 
synthesis [6]. Concomitantly, thiol modification of the sensor protein Keap1 activates the Nrf2 
pathway, leading to antioxidant responsive element-mediated induction of phase II detoxifying 
enzymes [7].  
The ITC sulforaphane (SFN) was initially identified as the principal inducer of anticarcinogenic 
protective enzymes from broccoli [8]. Subsequently, chemopreventive efficacy of SFN was 
demonstrated by inhibition of carcinogen-induced mammary and colon tumorigenesis and of 
intestinal adenoma formation in ApcMin/+ mice [9, 10]. Apart from its modulatory effects on 
carcinogen metabolism, induction of cell cycle arrest and apoptosis were identified as potential 
mechanisms contributing to the chemopreventive activities of SFN [4, 11]. In particular, SFN was 
shown to induce G2/M cell cycle arrest in a series of cancer cell lines derived from human colon, 
breast, prostate, and pancreas as well as in human leukemia cell lines [11-13]. On the other hand, 
non-transformed human T-lymphocytes and cultured human prostate and colon cancer cells were 
arrested by SFN treatment in G1 phase [11, 14-16]. In many of these cell lines, SFN-mediated cell 
cycle arrest was accompanied by induction of apoptosis (reviewed in [17-19]).  
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Under in vivo conditions, ITCs like SFN are readily absorbed, metabolized, and excreted via the 
mercapturic acid pathway with peak urinary levels at 1 and 1.5 h after ingestion [4, 11, 20]. The 
colon is one of the organs with highest exposure to ITCs, both systemically after absorption of 
free ITC, as well as topologically after ingestion of cooked cruciferous vegetables and subsequent 
release of ITCs from glucosinolates by the intestinal microflora [4, 11, 21]. In cell culture 
experiments, SFN and other ITCs accumulate intracellularly in the form of their GSH conjugates 
and can reach millimolar concentrations. Intracellular accumulation is dependent on sustained 
uptake; otherwise, ITC-glutathione conjugates are rapidly exported from the cells via a 
transporter-mediated process [22]. In this respect, we considered whether the results of in vitro 
studies with incubation times of 24 h or longer would be relevant for the human situation with 
short transient exposure to ITCs. In particular, using the human colon cancer cell line 40-16 we 
investigated how i) the duration of SFN treatment and ii) drug removal and recovery for up to 72 
h would influence cell proliferation and cell cycle progression. In addition, dose-dependent 
kinetics of GSH depletion and induction were analysed for a potential correlation with cytotoxic 
mechanisms.  
 
Materials and methods 
Chemicals. Sulforaphane (SFN, CAS no. 4478-93-7) was synthesized as described earlier 
[23]. All cell culture material was obtained from Invitrogen (Eggenstein, Germany). All material 
required for flow cytometry was purchased from Becton Dickinson (Franklin Lakes, NJ, USA). 
Fetal bovine serum was provided by PAA Laboratories (Pasching, Austria). McCoy’s 5A cell 
culture medium, sulforhodamin B (SRB), propidium iodide (PI) and RNase A and all other 
chemicals were obtained from Sigma (Taufkirchen, Germany).  
 
Inhibition of cell proliferation. The human colon cancer cell line 40-16 derived from 
HCT116 was provided by B. Vogelstein. We have previously investigated apoptosis-inducing 
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mechanisms of SFN in this cell line [24] and decided to utilize the same cell line for further 
studies for better comparison of results. McCoy’s 5A cell culture medium containing 5% fetal 
bovine serum was used throughout all experiments. Cells (2.5 x 104 cells/ml) were plated in 96-
well plates (200 µl/well). After overnight growth, cells were treated in duplicate with eight serial 
dilutions of SFN dissolved in DMSO (final DMSO concentration 0.5%) in a concentration range 
of 0.4 to 50 µM or with 0.5% DMSO as solvent control for 24 h, 48 h and 72 h. Alternatively, 
after treatment for either 3 h, 6 h, 12 h, or 24 h, cell culture medium was changed to SFN-free 
medium, and cells were incubated for up to 24 h, 48 h or 72 h, respectively, to allow recovery. 
Then the medium was discarded, and cells were fixed using 50 µl of 10% aqueous trichloroacetic 
acid (TCA) for 30 min at 4 °C. Sulforhodamin B staining was performed as described earlier [24]. 
Calculation of anti-proliferative activity was based on the ratio of absorbance readings of treated 
cells to those of solvent controls (set as 100%) after correction for absorbance of cells present at 
the time of treatment (day 0 values). Negative values indicate cytotoxic effects. In these cases, 
day 0 values of the control were used to calculate the percentage of cytotoxicity. IC50 values (half 
maximal inhibitory concentrations) were computed from the results of eight serial two-fold 
dilutions of SFN tested in duplicate from at least three independent experiments, using 
TableCurve Windows version 1.0 software (Jandel Scientific, San Rafael, USA) with the equation 
for a logistic dose-response curve. 
 
Cell Cycle Analysis. 40-16 cells were plated in 150 mm tissue culture dishes (1.75 x 106 
cells/35 ml). After overnight growth cells were treated with SFN at a concentration of 15 µM or 
with 0.2% DMSO as solvent control and incubated for 6 h, 12 h, 24 h or 48 h. For recovery 
experiments, cells were treated with SFN for 3 h, 6 h, 12 h or 24 h before cell culture medium was 
replaced by SFN-free medium. Incubation with drug-free medium was continued up to 48 h. 
Attached and floating cells were collected, washed with phosphate-buffered saline, pH 7.4 (PBS), 
fixed in ice cold 70 % ethanol and stored at -20 °C. After washing twice with PBS, cells were 
incubated with PBS containing propidium iodide (50 µg/ml) and RNase A (100 µg/ml) for 30 min 
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at 37 °C. Then they were analyzed by flow cytometry using a FACS Calibur with CELL QUEST 
PRO software (Becton Dickinson, Franklin Lakes, NJ, USA).  
 
Determination of GSH levels. 40-16 cells were seeded in 96-well plates 
(1 x 104 cells/well). SFN (final concentration 0.4-50 µM in 0.5% DMSO) was added 0.5-24 h 
prior to determination of total GSH levels. Plates were washed with PBS and stored at –80 °C 
until analyzed. GSH was measured as described previously using 5,5´-dithiobis-(2-nitrobenzoic 
acid) and normalized to protein concentrations determined using bicinchoninic acid [25].  
 
Statistical Analysis. Results are presented as means ± standard deviation (SD) of data 
originating from at least three independent experiments. For statistical evaluation, one-way 
ANOVA followed by Bonferroni’s multiple comparison test was applied. Values of p < 0.01 were 
considered as statistically significant.  
 
Results 
SFN-induced inhibition of cell proliferation: Influence of exposure and total incubation 
time. We have shown previously that SFN exhibits cytotoxic effects towards the 40-16 human 
colon cancer cell line with IC50 values of 7.7 µM, 6.6 µM and 5.7 µM after 24 h, 48 h and 72 h of 
continuous treatment, respectively [24]. In the present study, we analyzed SFN-induced effects on 
cell proliferation after shorter exposure times, and determined the reversibility of the observed 
effects after drug removal. In this respect, we treated 40-16 cells for 3 h to 24 h with SFN in a 
concentration range of 0.4 to 50 µM before cell culture medium was replaced by SFN-free 
medium. Cells were then allowed to recover for 24 h, 48 h and 72 h. Alternatively, SFN-
containing medium was not removed. As shown in Fig. 1A, treatment of 40-16 cells with SFN for 
3 h followed by recovery up to 72 h resulted in IC50 values of 21 µM, 22.3 µM and 22.6 µM. IC50 
values were not significantly influenced by the duration of recovery. After 6 h of SFN treatment, 
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IC50 values (10.8 to 13.1 µM) were about 50% lower than those measured after 3 h of incubation, 
but still twice as high as without recovery (5.4 to 6.6 µM). In contrast to these short treatment 
periods, 12 h and 24 h incubation with SFN resulted in irreversible cytotoxicity. Specifically, IC50 
values after 12 h of SFN treatment followed by recovery up to 72 h (6.4 to 8.1 µM) did not differ 
significantly from IC50 values obtained after 24 h to 72 h exposure without drug removal.  
A comparison of profiles of cell growth inhibition after SFN exposure for 3 to 24 h revealed 
obvious differences between short (up to 6 h) and longer (12 and 24 h) exposure times. An 
example of 48 h total incubation is given in Fig. 1B. SFN treatment for 3 h and 6 h resulted in 
cytostatic effects. Even at a concentration of 50 µM, cell numbers (i.e. absorbance values after 
SRB staining) were still above the initial baseline, indicating inhibition of cell proliferation, but 
no cytotoxicity. In contrast, after 12 h and 24 h exposure, SFN displayed cytotoxic effects at 
concentrations higher than 12.5 µM, measured by a reduction in cell numbers to values below the 
initial baseline. 
 
Effects of SFN on cell cycle cycle progression. SFN has been described to cause G1 or, 
more frequently, G2/M phase cell cycle arrest in various cancer cell lines [11-16]. Therefore, we 
were interested how effects of SFN on cell cycle progression in 40-16 cells would relate to the 
observed biphasic pattern in cell growth inhibition. Cells were treated with SFN at a concentration 
of 15 µM for 6 h to 48 h. Cell cycle distribution was assessed by flow cytometry after DNA 
staining with propidium iodide. Results are depicted as representative histograms in Fig. 2.  
SFN induced a cell cycle arrest in G2/M phase that was already visible after 6 h (41.4 ± 
4.3% vs. 29.5 ± 5.2% in the control). The accumulation of cells in G2/M phase increased with 
incubation time, with mean percentages of 51.2 ± 3.8% vs. 33.3 ± 2.9% after 12 h and 47.0 ± 
7.3% vs. 27.8 ± 2.1% after 24 h, respectively. After 48 h, the G2/M arrest was no longer 
detectable. In contrast, we observed a marked increase of cells in subG1 phase. This was in good 
agreement with our earlier investigations on the induction of apoptosis in 40-16 cells by 15 µM 
SFN [24]. 
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To further explain the results described in Fig. 1, cell cycle analyses were also performed 
to investigate the influence of the duration of SFN exposure and recovery time on cell cycle 
distribution. 40-16 cells were exposed to SFN at a concentration of 15 µM for increasing time 
periods from 3 h to 48 h and then harvested or allowed to recover for total incubation times up to 
48 h. The results are summarized in Table 1. Most relevant changes in sub-G1 and G2/M fractions 
are depicted in Fig. 3.  
SFN treatment for only 3 h already induced a significant increase in the G2/M fraction of 
the cells (36.4 ± 4.0%) compared to untreated control cells (25.1 ± 2.4%), concomitant with a 
reduction of cells in G0/G1 phase. After drug removal, cells were able to recover quickly: further 
incubation for 3 h in drug-free medium (6 h total incubation time) restored the percentage of cells 
in G2/M phase to control values.  
Continuous exposure to SFN for 6 h provoked a significant G2/M arrest (41.4 ± 4.3 %; 
compare Fig. 2 and 3), whereas G0/G1 and S phases were significantly reduced (for statistical 
evaluation see Table 1 and footnotes for explanation). The observed G2/M arrest was still evident 
after 6 h of recovery in SFN-free medium (12 h total incubation time: 43.8 ± 7.1%). The 
percentage of cells in S phase as an indicator of cell proliferation was further reduced at this time 
point (6 h: 26.8 ± 2.0% vs. 12 h: 19.5 ± 3.1%). Importantly, another 12 h of recovery (at a total 
incubation time of 24 h) abolished the G2/M arrest (25.8 ± 4.1%), although it was clearly evident 
after 24 h of continuous exposure to SFN (47.0 ± 7.3%; compare Fig. 2 and 3). These results 
indicated that the G2/M arrest induced by SFN treatment for 6 h was almost completely reversible.  
Continuous SFN exposure for 12 h resulted in the highest accumulation of cells in G2/M 
phase (51.2 ± 3.8% vs. 33.3 ± 2.9% in the untreated control; compare Fig. 2 and 3). Further 
incubation in drug-free medium up to 48 h led to a gradual decrease of G2/M-arrested cells, 
paralleled by an increase of cells in subG1 phase, indicative of apoptosis induction (total 
incubation time 24 h: 14.9 ± 6.9%; 48 h: 27.7 ± 8.8%; compare Fig. 3). Nevertheless, 48 h 
continuous exposure to SFN was significantly more effective in inducing apoptosis than 12 h 
treatment plus 36 h recovery time (45.5 ± 5.1% vs. 27.7 ± 8.8%). Of notice, we have demonstrated 
III. Manuscripts  –  2. Biphasic modulation of cell proliferation by sulforaphane…       72             
recently by Western Blotting via the detection of poly (ADP-ribose) polymerase cleavage that the 
percentage of cells in subG1 phase caused by SFN treatment directly correlated with apoptosis 
induction in the 40-16 cell line [26]. 
After 24 h incubation with SFN, G2/M phase arrest similar to that observed after 12 h was 
evident. At the same time point, a substantial portion of cells was apoptotic (23.2 ± 1.8% subG1 
vs. 4.3 ± 0.9% in the untreated control). When cells were incubated with SFN for 24 h and 
allowed to recover for further 24 h without SFN, there was no significant difference in the 
percentage of cells in subG1 phase compared to 48 h SFN treatment (40.2 ± 8.5% vs. 45.5 ± 5.1%; 
compare Fig. 3).  
Taken together, short treatment times with SFN for 3 h and 6 h led to a transient cell cycle 
arrest in G2/M phase, which was reversible after drug removal. After exposure for 12 h and 24 h, 
the early G2/M arrest turned into apoptosis induction with total incubation times of 24 h and 48 h, 
indicated by an increase in the percentage of cells in subG1 phase. Exposure of 40-16 cells to SFN 
for 12 h was sufficient for an irreversible commitment to cell death, which confirmed the results 
obtained with the cytotoxicity experiments depicted in Fig.1.  
 
Effects of SFN on cellular GSH levels. GSH depletion was suggested to play a role in 
SFN-induced cell cycle arrest and apoptosis [13, 27]. We therefore tested whether the kinetics of 
thiol depletion would be related to the growth inhibition profile observed with SFN. 40-16 cells 
were treated for 30 min to 24 h with SFN at concentrations of 6.25 µM, 12.5 µM and 25 µM. In 
addition, we used L-buthionine-S,R-sulfoximine (BSO), a specific inhibitor of γ-GCS [6], as 
positive control for GSH depletion.  
Treatment with BSO at a concentration of 10 µM for 16 h markedly lowered GSH levels 
to 26.4 ± 1.5% of the untreated control (Fig. 4). Of note, BSO exerted no cytotoxicity, since 
protein levels were not changed compared to control cells (data not shown). SFN treatment led to 
a rapid depletion in GSH levels within 30 min, especially at the two higher concentrations. After 
treatment with SFN at a concentration of 6.25 µM, GSH levels transiently decreased up to 4 h, 
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followed by gradual elevation to 159.5 ± 11.7% of the untreated control after 24 h, indicative of 
an induction of GSH synthesis. A similar trend was observed with the intermediate concentration, 
although the drop in GSH was more pronounced and longer lasting (minimum 49.5 ± 4.1% after 6 
h), and GSH resynthesis was slower with lower maximum induction, at least up to 24 h. In 
contrast, when cells were treated with 25 µM SFN, GSH levels dropped to a minimum of 29.5 ± 
3.2% after 10 h and did not recover, suggestive of irreversible cytotoxicity. 
 
Discussion 
In the present study we demonstrated that the time-dependent profile of cell growth inhibition by 
SFN was biphasic. Short exposure times up to 6 h led to cytostatic inhibition of cell proliferation, 
which was observed with concentrations up to 50 µM and was sustained up to 72 h even after 
drug-removal. Further, short exposure times resulted in a transient G2/M arrest, which was rapidly 
reversible when exposure was terminated after 3 h followed by drug-free incubation, and longer-
lasting, but still reversible when cells were treated for 6 h with 15 µM of SFN. On the other hand, 
treatment for at least 12 h caused cytotoxic inhibition of cell proliferation and was necessary to 
efficiently induce cell death. Detailed analyses of molecular mechanisms and a potential causal 
relation between cell cycle arrest in G2/M phase and apoptosis induction are currently underway 
(Pappa et al., in preparation). 
 
Gamet-Payrastre et al. investigated reversibility of SFN-induced apoptosis in HT29 human colon 
cancer cells. A minimum 24 h treatment was required for irreversible induction of cell death [28]. 
Synchronized cells treated with SFN were unable to reenter the cell cycle, but cell proliferation 
was initiated without signs of cytotoxicity after SFN removal. Thus, resting cells in G0 seemed to 
be resistant towards SFN. Zhang et al. [29] treated various cancer cell lines with SFN, phenethyl-
ITC, allyl-ITC and benzyl-ITC for 72 h or for 3 h followed by 69 h drug-free incubation. 
Interestingly, while IC50 values of SFN were significantly lower after 72 h continuous treatment 
compared to 3 h plus 69 h recovery time, IC50 values of the other three ITCs were similar for both 
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time regimes. Thus, SFN’s biphasic growth inhibition profile with delayed initiation of 
cytotoxicity seems to be unique for this ITC.  
Consistent with our data, SFN-induced G2/M arrest was reported to be irreversible after 16 h in 
PC-3 human prostate cancer cells [30]. In that study, the authors postulated that G2/M cell cycle 
arrest was due to oxidative stress-induced DNA damage. Using the dye 2',7'-
dichlorodihydrofluorescein diacetate sensitive to reactive oxygen species, we could not detect any 
significant enhancement of oxidative stress after treatment of 40-16 cells with 15 µM SFN for 
several time points (data not shown). 
A recent report demonstrated that significant oxidative stress and resulting DNA damage was 
correlated with depleted pools of mitochondrial and nuclear GSH, but not with cytoplasmic GSH 
levels [31]. Consistently, in the present study, reduced GSH levels due to inhibition of GSH 
synthesis by BSO [32] did not result in toxic effects or cell growth inhibition. Also, time- and 
dose-dependent depletion and resynthesis of GSH by SFN was not clearly related with cytotoxic 
potential. SFN treatment for 6 h at a concentration of 12.5 µM, which we assume to produce 
comparable effects on cell cycle and apoptosis induction as 15 µM used for the data summarized 
in Table 1, reduced GSH levels by 50%. This was associated with a transient cell cycle arrest in 
G2/M (Table 1) and cytostatic inhibition of cell proliferation (Fig. 1), but was not sufficient to 
induce cell death. In contrast to short incubation times, continuous exposure to 12.5 µM SFN for 
12 h and 24 h resulted in GSH resynthesis, while causing sustained G2/M arrest and commitment 
to undergo apoptosis. Higher concentrations of SFN resulted in stronger GSH depletion, but were 
merely cytostatic when exposure was discontinued after 3 and 6 h (Fig. 1B). Taken together, these 
data indicate that GSH depletion does not play a major role in SFN-induced apoptosis in the 40-
16 cell line, but may be related to the observed G2/M cell cycle arrest and cytostatic cell growth 
inhibition. Cytoplasmic GSH depletion may also be an indicator for intracellular SFN 
accumulation, which needs to be sustained for at least 12 h to cause irreversible cytotoxicity.  
Further pharmacokinetic investigations need to clarify which organs may be affected by SFN or 
its metabolites for 12 h or longer after ingestion of cruciferous vegetables. Regarding the colon, 
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the situation is unique due to the fact that this organ is exposed to SFN both systemically and 
topologically. The length of exposure to SFN and its metabolites then depends on the way in 
which vegetables are consumed (raw vs. cooked) and on intestinal transit time.  
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Figure legends: 
 
Fig. 1. Time-dependent inhibition of cell proliferation by SFN and the effect of drug removal. (A) 
Inhibition of cell proliferation was determined by sulforhodamine B staining. Cells were treated 
with eight different concentrations of SFN (0.4 to 50 µM) or 0.5% DMSO as a solvent control for 
3 h, 6 h, 12 h, 24 h before replacement of SFN-containing cell culture medium by SFN-free 
medium and further incubation for up to 24 h (black bars), 48 h (grey bars) or 72 h (stippled bars). 
Alternatively cells were treated continuously (nr, no removal) for 24 h (black bar), 48 h (grey bar) 
or 72 h (stippled bar), respectively. IC50 values were calculated as described in “Materials and 
methods”. Data are means ± SD of three independent experiments. a significantly different (p < 
0.01) compared with 3 h SFN treatment within the same total incubation time. b significantly  
different (p < 0.01) compared with 3 h and 6 h SFN treatment within the same total incubation 
time.  
 (B) Profiles of cell growth inhibition after treatment with SFN for 3 h to 24 h as indicated, before 
cell culture medium was changed to drug-free medium (nr, no removal). Data were taken from 
one representative cell proliferation experiment with a total incubation time of 48 h. Dose-
dependent inhibition of proliferation is shown by values above the baseline, whereas values below 
the baseline represent cytotoxic effects. 
 
Fig. 2. Cell cycle effects of SFN. 40-16 cells were treated with SFN (15 µM) or 0.2% DMSO 
(untreated control) for 6 h, 12 h, 24 h or 48 h, respectively. Cell cycle analyses of fixed cells were 
performed by flow cytometry after staining DNA with propidium iodide. Representative 
histograms of one out of four independent experiments are depicted. 
 
Fig. 3. SFN-induced cell cycle effects and the influence of exposure time and drug removal. Data 
were taken from Table 1. 40-16 cells were treated with SFN (15 µM) or 0.2% DMSO for 3 h, 6 h, 
12 h or 24 h before medium change and drug-free incubation for up to 48 h total incubation time. 
III. Manuscripts  –  2. Biphasic modulation of cell proliferation by sulforaphane…       82             
Alternatively, cells were treated with SFN continuously for 3 h, 6 h, 12 h, 24 h or 48 h, 
respectively (nr, no removal, represented by stippled bars). Cell cycle analyses of fixed cells were 
performed by flow cytometry after staining DNA with propidium iodide. Data for G2/M and 
subG1 phase are shown as means ± SD of four independent experiments. Letters indicate 
significant differences as in Table 1. 
 
Fig. 4. Effects of SFN on total intracellular GSH levels. 40-16 cells were treated with SFN for 0.5 
- 24 h. Results obtained with SFN at 6.25 µM (black bars), 12.5 µM (light grey bars) and 25 µM 
(stippled bars), and BSO (10 µM, 16 h, dark grey bar) as a positive control are shown as 
percentage of the respective solvent control. Means ± SD significantly different (p < 0.01) from a 
respective control, b control and 6.25 µM, c control, 6.25 µM and 12.5 µM, d preceding time point 
with identical SFN treatment (n = 3). GSH levels in the controls were in the range of 55 to 80 
pmol/µg protein. 
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Table 1 Summary of reversibility experiments of SFN-induced cell cycle effects (mean ±SD) 
total incubation 
time [h] subG1 [%] G0/G1 [%] S [%] G2/M [%] 
Control (no SFN treatment) 
3  2.1 ± 0.5 47.0 ± 3.5 25.9 ± 3.0 25.1 ± 2.4 
6  2.3 ± 0.7 36.5 ± 3.7 a  31.9 ± 3.9 a 29.5 ± 5.2 
12  3.1 ± 0.5 37.0 ± 1.9 26.4 ± 0.9 a 33.3 ± 2.9 
24  4.3 ± 0.9 42.8 ± 2.3  24.4 ± 2.1 27.8 ± 2.1 
48  4.1 ± 0.7 56.1 ± 4.5 a  19.1 ± 3.3 20.4 ± 1.8 a  
 
Treatment with SFN (15 µM) for 3 h 
3  2.4 ± 0.2 36.9 ± 1.6 b  24.4 ± 3.2 36.4 ± 4.0 b 
6  2.4 ± 0.5 42.4 ± 1.7 a  25.9 ± 1.6 b 29.3 ± 3.0 a 
12  2.8 ± 0.4 42.8 ± 4.8 19.4 ± 2.1 b  33.9 ± 4.0 
24  6.3 ± 4.1 37.8 ± 3.0 22.7 ± 3.7 31.1 ± 1.4 
48  6.1 ± 1.8 50.7 ± 2.5 a 20.2 ± 2.6 22.1 ± 2.0 a  
 
Treatment with SFN (15 µM) for 6 h 
6  3.4 ± 0.5 c 28.2 ± 6.0 c 26.8 ± 2.0 b 41.4 ± 4.3 c 
12  4.2 ± 1.1 30.9 ± 10.1 19.5 ± 3.1 a,b  43.8 ± 7.1 b 
24  7.1 ± 3.6 37.0 ± 10.1 23.4 ± 5.4 25.8 ± 4.1 a  
48  9.6 ± 2.5  43.4 ± 7.3 b  18.6 ± 3.5 26.9 ± 4.0 
 
Treatment with SFN (15 µM) for 12 h 
12  7.4 ± 2.4 d  21.6 ± 3.6 c  18.7 ± 2.0 b  51.2 ± 3.8 c  
24  14.9 ± 6.9 b  35.7 ± 10.6 11.1 ± 1.5 a,d  33.6 ± 4.7 a  
48  27.7 ± 8.8 d  23.2 ± 6.3 d  16.0 ± 3.1 25.4 ± 2.9 a 
 
Treatment with SFN (15 µM) for 24 h 
24  23.2 ± 1.8 d  16.1 ± 2.6 e  12.2 ± 4.4 d  47.0 ± 7.3 e  
48  40.2 ± 8.5 a,e  12.3 ± 1.4 d  16.0 ± 1.4 25.0 ± 5.9 a  
 
Treatment with SFN (15 µM) for 48 h 
48  45.5 ± 5.1 e  14.0 ± 6.8 d  14.4 ± 3.5 24.4 ± 5.2 
a
 mean significantly different (p < 0.01) from preceding total incubation time without SFN 
treatment (control) or within the same SFN treatment time 
b
 significantly different (p < 0.01) from untreated control of the same total incubation time 
c
 significantly different (p < 0.01) from untreated control and from 3 h treatment with SFN within 
the same total incubation time 
d
 significantly different (p < 0.01) from untreated control and from 3 h and 6 h treatment with 
SFN within the same total incubation time 
e
 significantly different (p < 0.01) from untreated control and from 3 h, 6 h and 12 h treatment 
with SFN within the same total incubation time 
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Fig. 1 
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Fig. 3  
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Fig. 4 
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Abstract  
Isothiocyanates and indoles derived from cruciferous vegetables possess growth-inhibiting and 
apoptosis-inducing activities in cancer cell lines in vitro. Isothiocyanates like sulforaphane (SFN) 
are cytotoxic, whereas indoles including indole-3-carbinol or its condensation product 3,3’-
diindolylmethane (DIM) are acting by cytostatic mechanisms in human colon cancer cell lines. In 
the present study, we have investigated the impact of defined combinations of SFN and DIM 
(ratio 1:4, 1:2, 1:1, 2:1 and 4:1) on cell proliferation, cell cycle progression and apoptosis 
induction in cultured 40-16 colon carcinoma cells. Calculations of combination effects were based 
on the method of Chou and Talalay (1984), and were expressed as a combination index (CI) with 
CI<1, CI=1 or CI>1 representing synergism, additivity or antagonism, respectively. Interestingly, 
at a total drug concentration of 2.5 µM, all combinations of SFN and DIM were antagonistic. 
With increasing concentrations, the antagonistic effect gradually turned into a synergistic 
interaction at the highest combined cytotoxic concentration of 40 µM. Cell cycle analyses with 
SFN:DIM ratios of 1:1, 1:2 and 1:4 and total concentrations between 10 and 25 µM confirmed 
antagonism at low, and additive effects at higher doses. SFN (10 µM) in combination with DIM 
(10 µM) resulted in strong G2/M cell cycle arrest which was not observed with either compound 
alone. Our results indicate that cytotoxic concentrations of SFN:DIM combinations affect cell 
proliferation synergistically. At low total concentrations (below 20 µM), which are 
physiologically more relevant, the combined broccoli compounds showed antagonistic 
interactions in terms of cell growth inhibition. These data stress the need for elucidating 
mechanistic interactions for better predicting beneficial health effects of bioactive food 
components.  
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1. Introduction 
Cruciferous vegetables, in particular those of the Brassica genus (broccoli, cabbage, cauliflower, 
radish, mustard etc.) possess cancer preventive potential in vitro and in vivo that has been 
attributed to their content in thioglucoside conjugates, namely glucosinolates [1,2]. Through 
catalytic mediation of myrosinase (β-thioglucosidase), which is released upon physical damage of 
plant cells (e.g. during cutting or chewing), glucosinolates are hydrolyzed, releasing the 
corresponding isothiocyanates (ITCs). 
The ITC sulforaphane (SFN) is particularly abundant in broccoli (Brassica oleracea L. var. 
italica) as its corresponding glucosinolate glucoraphanin [3]. In 1992, Zhang et al. initially 
identified SFN as a principal inducer of phase II enzymes including NAD(P)H:quinone 
oxidoreductase in broccoli [4]. Subsequently, chemopreventive efficacy of SFN was demonstrated 
by inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis, of 
azoxymethane-induced colonic aberrant crypt foci formation in rats [5,6] and of intestinal 
adenoma formation in ApcMin/+ mice [7,8]. Apart from its modulatory effects on carcinogen 
metabolism, induction of cell cycle arrest and apoptosis in various cancer cell lines were 
identified as mechanisms underlying the chemopreventive activities of SFN [9-13].  
Mature broccoli is also rich in the indole-based glucosinolate glucobrassicin. Cleavage by 
myrosinase results in an unstable ITC that is further converted to indole-3-carbinol and other 
indole derivatives [3]. Under low pH conditions, as in the stomach, several condensation reactions 
of indole-3-carbinol occur which result in the formation of 3,3’-diindolylmethane (DIM) as a 
major condensation product [14]. Based on this observation, it has been suggested that DIM rather 
than indole-3-carbinol is responsible for the physiological effects of dietary indole-3-carbinol 
observed in vivo [15,16].  
Both indole-3-carbinol and DIM possess cancer protective effects in reproductive organs, which 
are supposed to be due to the induction of specific cytochrome P450 enzymes involved in 
estrogen metabolism [17-19]. Indole-3-carbinol and DIM were also found to suppress cell 
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proliferation and to induce apoptosis in breast, prostate, cervical and colon cancer cell lines 
[10,20,21], partly mediated by cell cycle arrest in the G1 phase [22-24].  
Numerous bioactive plant constituents are concertedly consumed with a diet rich in fruits and 
vegetables that is supposed to reduce cancer risk. It has been suggested that synergistic effects of 
combined low doses of these phytochemicals may account for the observed health benefits [25]. 
Although intense research is being conducted to reveal molecular mechanisms of 
chemopreventive activities and to demonstrate chemopreventive efficacy of single pure plant 
constituents, only few studies have been undertaken to systematically quantitate combination 
effects of these compounds. With respect to glucosinolate cleavage products and other substances 
found in Brassica vegetables, El-Bayoumy et al. demonstrated that a mixture of 1,4-
phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinole and d-
limonene was significantly more potent in inhibiting lung tumor multiplicity in A/J mice than 
indole-3-carbinol alone, but not than either of the other single compounds [26]. A synergistic 
induction of phase II enzymes was shown in rats treated with indole-3-carbinol and crambene 
(derived from the glucosinolate progoitrin) [27,28]. In a later study the same group reported that 
only a relatively high, non-physiological dose of a combination of indole-3-carbinol and 
crambene was able to reduce aflatoxin B1-induced expression of the preneoplastic marker 
glutathione S-transferase pi in rats [29].  
In extension of these studies focusing on the impact of combined broccoli compounds on the 
initiation stage of carcinogenesis, we were interested in how later stages would be affected by a 
mixture of SFN and DIM, using cell proliferation as an example. Interestingly, ITCs and indole 
derivates exert their anti-proliferative effects - at least in part - by different mechanisms. Recently, 
we have demonstrated that ITCs like SFN are cytotoxic in human colon cancer cell lines, whereas 
indoles like indole-3-carbinol or DIM are acting by a cytostatic mechanism [30]. Moreover, 
indoles were shown to halt the cell cycle in G1 [21], while ITCs induce cell cycle arrest in G2/M 
phase [31]. 
III. Manuscripts  –  3. Quantitative combination effects…                                              92             
 
Thus, the aim of the present report was to quantify combination effects between the broccoli 
compounds SFN and DIM as representatives for ITCs and indoles, respectively, with regard to 
cell growth inhibition, cytotoxicity and on cell cycle distribution in the human colon cancer cell 
line 40-16. 
 
2. Materials and Methods 
Chemicals 
Sulforaphane (SFN, CAS no. 4478-93-7) was synthesized as described earlier [32]. 3,3’-
Diindolylmethane (DIM, CAS no. 1968-05-4) was purchased from LKT Laboratories Inc. 
(Minnesota, USA). All cell culture material was obtained from Invitrogen (Eggenstein, Germany). 
Fetal bovine serum was provided by PAA Laboratories (Pasching, Austria). McCoy’s 5A cell 
culture medium, sulforhodamin B (SRB), propidium iodide (PI) and RNase A were obtained from 
Sigma (Taufkirchen, Germany). All material required for flow cytometry was purchased from 
Becton Dickinson (Franklin Lakes, NJ USA). The antibody against PARP (#9542) was obtained 
from Cell Signaling Technology (Beverly, USA). Anti-mouse- and anti-rabbit-secondary 
antibodies were obtained from Santa Cruz (Heidelberg, Germany). β-Actin antibody AC-15 
(A5441) was purchased from Sigma (Taufkirchen, Germany). Materials and equipment for gel 
electrophoresis were purchased from Bio-Rad (Munich, Germany). All other chemicals were from 
Sigma (Taufkirchen, Germany).  
 
Inhibition of cell proliferation 
The human colon cancer cell line 40-16, derived from a random HCT116 clone, was generously 
provided by B. Vogelstein from Johns Hopkins Oncology Center (Baltimore, USA). Cells were 
cultured as described earlier [30]. 
For combination experiments 40-16 cells (2.5 x 104 cells/ml in McCoy’s 5A medium) were plated 
in 96-well plates (200 µl/well). After overnight growth, cell culture medium was changed and 
cells were treated with SFN or DIM dissolved in DMSO (final DMSO concentration 0.5%) in a 
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concentration range of 0.3 to 40 µM, respectively. Alternatively, cells were treated with the 
combination of SFN and DIM (molar ratios 1:4, 1:2, 1:1, 2:1 and 4:1). Eight serial two-fold 
dilutions of the following starting concentrations were applied: 10 µM SFN + 40 µM DIM (1:4), 
20 µM SFN + 40 µM DIM (1:2), 20 µM SFN + 20 µM DIM (1:1), 40 µM SFN + 20 µM DIM 
(2:1) and 40 µM SFN + 10 µM DIM (4:1). Cells were treated with 0.5% DMSO as solvent 
control. After incubation for additional 24 h, 48 h or 72 h, respectively, the medium was discarded 
and cells were fixed using 50 µl of 10% aqueous trichloro acetic acid (TCA) for 30 min at 4 °C. 
Sulforhodamin B staining was performed as described by Skehan et al. [33]. Calculations of anti-
proliferative activities were based on the ratio of absorbance readings of treated cells to those of 
solvent controls. Absorbance readings were corrected for absorbance of cells present at the time 
of treatment (day 0 values) in order to distinguish between cytostatic and cytotoxic effects. 
Negative values indicate cytotoxicity. In these cases, day 0 values of the control were used to 
calculate the percentage of cytotoxicity. IC50 values (half maximal inhibitory concentrations) were 
computed from the results of eight serial two-fold dilutions of test compound tested in duplicate 
from at least three independent experiments, using Table Curve Windows version 1.0 software 
(Jandel Scientific, San Rafael, USA) with the equation for a logistic dose-response curve. The 
percentage of cell growth inhibition was alternatively expressed as affected fraction (fa), with 
values between 0 and 0.5 for cytostatic effects, and 0.5 to 1 for cytotoxic effects.  
 
Calculation of combination effects 
Combination effects of SFN and DIM on cell growth inhibition were calculated according to 
Chou and Talalay [34]. Briefly, for median-effect plots, log (fa/fu) was plotted against log (D), 
where D represents the concentration of each single compound alone or the mixture of both, and 
fa and fu stand for the affected (values between 0 and 1) and unaffected (1-fa) fraction, 
respectively, at each concentration D.  
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Using CalcuSyn software (Biosoft, Ferguson, MO USA), which is based upon the method by 
Chou and Talalay [34], a combination index (CI) was computed for every fraction affected. CI<1, 
CI=1 or CI>1 represent synergism, additivity or antagonism of SFN and DIM, respectively. For 
the generation of CI-effect plots, original data points were taken and simulation curves were 
calculated for each experiment using Table Curve Windows version 1.0 software (Jandel 
Scientific, San Rafael, USA). These simulation curves were also used for adjusting CI values to 
fixed total concentrations.  
 
Cell Cycle Analysis  
40-16 cells were plated in 150 mm tissue culture dishes (1.75 x 106 cells/35 ml) and treated as 
indicated in figure legends after overnight growth. Attached and floating cells were collected, 
washed with PBS, fixed in ice cold 70% ethanol and stored at –20 °C. After washing twice with 
PBS, cells were incubated with PBS containing propidium iodide (50 µg/ml) and RNase A (100 
µg/ml) for 30 min at 37 °C. Then they were analyzed by flow cytometry using a FACS Calibur 
(Becton Dickinson, Franklin Lakes, NJ, USA). After discrimination of doublets, the percentage of 
cells in each phase of the cell cycle was determined by setting markers with CELL QUEST PRO 
software (Becton Dickinson, Franklin Lakes, NJ, USA).  
 
Western Blot Analysis 
40-16 cells were plated in 100 mm tissue culture dishes (2.5 × 105 cells/10 ml) and treated as 
indicated in the figure legend after overnight growth. Attached and floating cells were collected, 
lysed and homogenized in SDS lysis buffer (62.5 mM Tris HCl, pH 6.8, 2% (w/v) SDS, 10% 
glycerol, 50 mM DTT, 0.01% (w/v) bromphenol blue). The protein content was determined using 
the bicinchoninic acid method [35] after precipitation with cold 10% TCA. Total protein (ca. 
15 µg/lane) was subjected to 10% acrylamide SDS-PAGE under standard conditions and 
electroblotted onto polyvinylidene difluoride membranes in 15% methanol, 25 mM Tris, and 
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192 mM glycine. The membranes were blocked with 5% nonfat milk in Tris-buffered saline 
(10 mM Tris, pH 7.4, 100 mM NaCl) containing 0.05% Tween 20 for 1.5 h at RT and incubated 
with anti-PARP antibody (1:1000) overnight at 4 °C. After washing, the membranes were 
incubated with secondary antibody (1:10 000) conjugated with horseradish peroxidase for 1 h at 
RT. The membranes were developed using a chemiluminescence system. Equal protein loading 
per lane was ensured by using an anti-β-actin antibody (1:10 000).  
 
Statistical Analysis 
Results are presented as means ± standard deviation of data originating from at least three 
independent experiments. For statistical evaluation one-way ANOVA and Tukey’s studentized 
range test was applied. Values of p < 0.05 were considered as statistically significant.  
 
3. Results 
Anti-proliferative effects of SFN and DIM  
Incubation of 40-16 human colon cancer cells with SFN or DIM (Figure 1) at a concentration 
range of 0.3 to 40 µM led to a dose-dependent inhibition of cell proliferation. IC50 values obtained 
after 24 h, 48 h and 72 h of treatment were 6.8 ± 0.4 µM, 6.6 ± 0.5 µM, and 8.2 ± 0.4 µM for 
SFN, and 11.6 ± 1.7 µM, 10.1 ± 1.9 µM, and 6.8 ± 0.9 µM for DIM, respectively. Interestingly, 
after an incubation time of 24 h, SFN was significantly more effective in suppressing cell growth 
than DIM (p = 0.009), whereas after 72 h, DIM had a lower IC50 value than SFN. Accordingly, 
SFN was less toxic after 72 h compared to 24 h and 48 h incubations, whereas DIM’s 
effectiveness increased with elongated treatment times.  
Comparison of growth inhibition profiles clearly indicated that SFN was cytotoxic at 
concentrations higher than 10 µM, demonstrated by fa values higher than 0.5 (as described in 
Materials and Methods). On the other hand, the dose-response curves obtained with DIM revealed 
a cytostatic profile, as shown in a representative dose-effect plot (Figure 2). These results are in 
congruence with our recently reported observations [30].  
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Anti-proliferative effects of combinations of SFN and DIM 
To determine combination effects of SFN and DIM on cell proliferation, cells were treated with 
constant molar ratios of the two drugs (1:4, 1:2, 1:1, 2:1 and 4:1) using eight serial two-fold 
dilutions of each mixture for 24 h, 48 h and 72 h. As an example, a dose-effect curve of the 1:1 
mixture after 48 h of incubation is included in Figure 2. Notably, at the two highest total 
concentrations (20 and 40 µM), the fraction fa affected by the mixture was lower than that of 
SFN, but higher than that of DIM. In contrast, total concentrations below 20 µM inhibited cell 
growth less than either compound alone.  
 
Quantification of combination effects according to Chou and Talalay 
The method by Chou and Talalay is a widely accepted approach to analyze synergistic, additive or 
antagonistic effects of two compounds [34]. The first step of the procedure is to assess mutual 
exclusivity of the test compounds by generating median-effect plots, with log (fa/fu) plotted 
against log (D) (see Material and Methods). Parallelism of the regression lines obtained for either 
compound alone and the mixture of both indicates that two drugs are mutually exclusive, i.e. they 
have the same target or mode of action. If the lines are not in parallel, the tested compounds are 
mutually non-exclusive, i.e. they act independently or have different modes of action. As shown 
in Figure 3, the regression lines of SFN, DIM and the 1:1 mixture were not in parallel. We 
therefore concluded that SFN and DIM are mutually non-exclusive and inhibit cell proliferation 
by different mechanisms. Additional median-effect plots generated for all combination 
experiments with molar ratios of SFN and DIM of 4:1, 2:1, 1:1, 1:2, and 1:4, and for 24 h, 48 h, 
and 72 h of incubation, respectively, further confirmed these results (data not shown).  
In order to determine whether SFN and DIM influenced each other in a synergistic, additive or 
antagonistic manner, we used the CalcuSyn software to determine combination indices (CI) for all 
combinations and incubation times described above. CI values lower and higher than 1 indicate 
synergism and antagonism, respectively, whereas additive effects result in a combination index of 
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1. A representative CI-effect plot for the 1:1 combination of SFN and DIM after 48 h of treatment 
is depicted in Figure 4. At low effects provoked by high dilutions of the SFN:DIM combination, 
CI values were between 1 and 3, indicating that cell proliferation was affected in an antagonistic 
manner. However, CI values decrease with increasing effects. At the highest effects observed with 
highest SFN:DIM concentrations, CI values were even below 1, demonstrating that cytotoxic 
concentrations of the 1:1 combination inhibit cell proliferation synergistically.  
 
SFN and DIM are antagonistic at low and synergistic at high concentrations  
Since the effects of SFN:DIM combinations could not be directly compared due to different total 
concentrations, we adjusted the obtained CI values to the fixed total concentrations of 2.5, 5, 10, 
20 and 40 µM by generating simulation curves from the original results. Data for five SFN:DIM 
combinations and increasing incubation times are summarized in Figure 5. In agreement with the 
results described above, CI values computed for low combined drug concentrations were higher 
than 1, indicating antagonism in terms of cell growth inhibition. The highest CI value of 4.2 ± 2.2 
was calculated for the 1:4 combination after 24 h of treatment. Increasing concentrations resulted 
in decreasing CI values. Combinations of SFN and DIM showed synergistic effects (CI < 1) only 
at the highest total drug concentration (40 µM), except for the 1:4 combination after 72 h of 
treatment. Synergism was strongest when the cells were treated with the 1:2 mixture of SFN and 
DIM for 24 h. At a total concentration of 20 µM, the two compounds influenced each other either 
additively (e.g., CI = 1.0 for the 1:2 combination after 24 h) or antagonistically (e.g., CI = 1.6 for 
the 1:1 combination after 72 h).  
Taken together, low to moderate total concentrations of SFN:DIM combinations (2.5 to 20 µM) 
appear to inhibit proliferation of 40-16 cells in an antagonistic manner, whereas at cytotoxic total 
concentrations of 40 µM or higher, the compounds act in a synergistic manner. Overall, 
depending on the total concentration, strongest antagonistic and synergistic effects were observed 
i) after short incubation times, and ii) when DIM was present in excess of SFN.  
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Cell cycle effects of SFN, DIM and their combinations  
Previous studies have established that SFN and DIM both halt cell cycle progression in cultured 
tumor cells. Notably, while in many cancer cell lines SFN induces cell cycle arrest in G2/M phase 
[31], DIM provokes a stop in G1 [21]. We therefore addressed the question how SFN:DIM 
combinations would affect cell cycle progression of 40-16 cells. We performed cell cycle analyses 
with cells treated with either SFN (5 µM or 10 µM) or DIM (10 µM) alone, or mixtures thereof. 
We used the same fixed molar ratios as described for cytotoxicity experiments, with the exception 
of combinations with an excess of SFN (SFN:DIM 2:1 and 4:1). Preliminary experiments had 
indicated that SFN in excess of DIM completely abrogated DIM’s effects on cell cycle 
progression. Cells were arrested in G2/M phase similarly as with SFN alone (data not shown). 
Thus, we tested 5 µM SFN in combinations with increasing concentrations of DIM (5, 10 and 20 
µM, molar ratios of 1:1, 1:2, and 1:4). Additionally, cells were treated with a 1:1 mixture of 
10 µM of each compound.  
After 24 h of treatment, DIM (10 µM) and the lower dose of SFN (5 µM) as well as the 
combination of 5 µM SFN + 5 µM DIM had no effect on the sub-G1 fraction, whereas SFN at a 
10 µM concentration significantly induced a sub-G1 peak indicative of apoptosis induction 
(Figure 6). Addition of increasing concentrations of DIM to 5 µM of SFN resulted in increasing 
effects. Strongest apoptosis induction was observed with the combination containing 10 µM SFN 
+ 10 µM DIM (23.9 ± 2.2% sub-G1). Increases in sub-G1 fractions were accompanied by 
significant reduction in S phase as a further sign of cell growth inhibition. Neither treatment with 
the compounds alone nor with combinations influenced the fraction of cells in G1 or in G2/M 
phase, with the exception of the 10 µM SFN + 10 µM DIM mixture, which provoked a strong 
G2/M arrest (52.8 ± 5.2% vs. 26.8 ± 2.3% in untreated control cells). Consequently, the fraction of 
cells in G1 was significantly reduced (15.5 ± 5.1%) in comparison with the control (44.0 ± 3.1%).  
After 48 h of treatment, SFN (5 µM) and DIM (10 µM) had weak, but non-significant effects on 
cell cycle distribution. Further, combining 5 µM SFN with 5 µM or 10 µM DIM did not lead to a 
significant enhancement of effects when compared with the untreated control or with 5 µM SFN 
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or 10 µM DIM, respectively. This may point to an antagonistic interaction. SFN at a 10 µM 
concentration was more potent in inducing the percentage of cells in sub-G1 (28.6 ± 5.8%) than 5 
µM SFN + 20 µM DIM. Addition of 10 µM DIM to 10 µM SFN further increased the sub-G1 
peak induced by SFN (41.1 ± 6.5%). Concomitantly, the percentage of cells in G1 and S phase 
was significantly reduced by these treatment regimens. As observed after 24 h, the combination of 
10 µM SFN with 10 µM DIM caused a significant G2/M cell cycle arrest. 
 
Effects of SFN, DIM and their combinations on PARP cleavage 
To confirm the apoptosis-inducing potential of SFN and DIM combinations, we analyzed 
cleavage of the DNA repair enzyme PARP [poly (ADP-ribose) polymerase] by Western blotting 
(Figure 7). After 24 h of treatment, SFN alone at a concentration of 10 µM, as well as the 10 µM 
SFN + 10 µM DIM mixture induced PARP cleavage, which is consistent with the increase of the 
sub-G1 fraction observed with cell cycle analyses. Treatment with 5 µM SFN + 20 µM DIM for 
24 h was not sufficient to trigger PARP cleavage.  
After 48 h, PARP cleavage was markedly induced by SFN (10 µM) and the mixtures of 10 µM 
SFN + 10 µM DIM and 5 µM SFN + 20 µM DIM. The effect produced by the latter combination 
was approximately equivalent to the 10 µM SFN + 10 µM DIM mixture after 24 h, which is 
consistent with sub-G1 peak induction.  
 
4. Discussion 
In the present study, we have demonstrated that combinations of SFN and DIM, two 
chemopreventive compounds derived from cruciferous vegetables like broccoli, inhibit the growth 
of cultured human colon cancer cells antagonistically at low concentrations, but synergistically at 
cytotoxic concentrations. First, we determined the anti-proliferative potential of SFN and DIM 
alone in the 40-16 human colon carcinoma cell line. IC50 values as low as 6.6 to 11.6 µM 
underline the strong ability of SFN and DIM to inhibit tumor cell growth. We confirmed that SFN 
is a cytotoxic agent, whereas DIM has a cytostatic profile of cell growth inhibition [30]. Also, 
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SFN and DIM were found to be mutually non-exclusive, which is not surprising, since 
fundamental differences in the growth inhibition profiles of the two compounds as well as 
different effects on cell cycle distribution have been reported previously [21,30,31].  
A dose-response curve obtained with a 1:1 mixture of SFN and DIM in comparison with the 
single compounds clearly indicated that at high total concentrations (20 µM SFN and 20 µM 
DIM), the mixture was more active than either compound alone. In contrast, at low total 
concentrations, the dose-response curve of the mixture was below those of SFN and DIM alone, 
suggesting antagonistic interaction. This observation prompted us to quantitate combination 
effects of SFN and DIM using the method of Chou and Talalay [34]. Results of these analyses 
indicated that combinatory interactions between SFN and DIM are strongly dose-dependent, in 
that low combined concentrations are antagonistic, whereas cytotoxic concentrations are 
synergistic, regardless of the ratio applied. A possible explanation for this phenomenon might be 
that at low concentrations, mechanisms other than cell cycle arrest or apoptosis induction play a 
more prominent role for chemopreventive potential. In a majority of in vitro studies on apoptosis 
induction, including our investigation in the 40-16 cell line, SFN or DIM had to be applied at 
concentrations of at least 10 µM to induce apoptosis [30,36,37]. In contrast, SFN at 
concentrations as low as 1 - 5 µM was very effective in inducing phase II detoxification enzymes 
[38-40], whereas DIM affected biotransformation enzymes only at concentrations higher than 
20 µM [21,38,41]. Therefore, treatment with low doses of SFN might cause increased 
‘detoxification’ of the compounds themselves or of reactive intermediates involved in inhibition 
of cell proliferation, resulting in the observed antagonistic effects.  
In the present study, only relatively high concentrations of combinations of SFN and DIM were 
able to inhibit cell proliferation or induce cell death in a synergistic manner, whereas intermediate 
concentrations (SFN + DIM = 20 µM) were weakly antagonistic or additive. Since SFN and DIM 
alone induce G2 and G1 cell cycle arrest, respectively [21,31], antagonism could also be explained 
by these opposing effects. To address this question, we performed cell cycle analyses with 
mixtures of SFN and DIM in ratios of 1:4, 1:2 and 1:1, with total drug concentrations ranging 
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from 10 to 25 µM. Due to the distribution of analyzed cells to four different fractions (sub-G1, 
G0/G1, S, and G2/M), flow cytometry data were not suitable to calculate combination indices. 
Therefore, influences on cell cycle phases had to be compared directly.  
Again, effects of SFN, DIM and their combinations strongly depended on total drug 
concentrations tested. Most interesting effects were observed with SFN alone at a concentration of 
10 µM and mixtures of either 5 µM SFN + 20 µM DIM or 10 µM SFN + 10 µM DIM, whereas 
DIM at a 10 µM concentration did not cause any change in cell cycle distribution. Notably, 
addition of 10 µM DIM to 10 µM SFN significantly arrested cells in G2/M and enhanced the 
effect of SFN alone (10 µM) with respect to reduction of the percentage of cells in G1 and S phase 
as well as induction of a sub-G1 peak. Since the 10 µM SFN + 10 µM DIM combination affected 
all phases of the cell cycle, the net result may be inhibition of cell proliferation, but not 
necessarily a strong enhancement of cytotoxic effects. This was confirmed when cell death was 
analyzed by the detection of PARP cleavage with Western Blotting. Cell cycle effects of the 5 µM 
SFN + 20 µM DIM mixture resembled those of SFN at a 10 µM concentration, although PARP 
cleavage was only detectable after 48 h of treatment with the combination. These data indicate 
that a threshold concentration of around 10 µM of SFN is necessary to sensitize cells to cell death, 
but DIM addition might modulate cell growth inhibition by enhancing the G2/M arresting 
potential of SFN. Numerous attempts have been made to elucidate the mechanism how SFN 
induces G2/M arrest. Reactive oxygen species-mediated DNA damage as well as disruption of 
tubulin polymerization have been proposed [12,42]. Further investigations have to clarify how 
DIM interacts with these mechanisms. Since SFN has also been described to cause G1 arrest, e.g. 
in the HT-29 colon cancer cell line [43], further investigations with other cells line will be 
required to confirm the general validity of these results. 
In terms of synergistic or antagonistic interactions between SFN and DIM, data obtained from cell 
cycle and Western blot analyses are consistent with data of the cell growth experiments. Low 
concentrations of combinations seem to be antagonistic, whereas higher total concentrations seem 
to act rather additive or weakly synergistic, especially in the case of the 10 µM SFN + 10 µM 
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DIM combination. Although the impact on cell cycle phases differed depending on the ratio of 
SFN and DIM, CI values obtained from cytotoxicity data were similar regardless of the applied 
ratio of the two drugs. 
A dose-dependent switch from antagonistic to synergistic interaction between two compounds has 
been reported before. Khafif et al. observed synergism of the green tea compound (-)-
epigallocatechin-3-gallate (EGCG) and the spice curcumin in inhibiting cell growth of 
differentially transformed human oral epithelial cell lines [44]. The authors described antagonistic 
interactions at low doses of the drug combination, which were selective for normal or less 
progressed cells, but a synergistic growth-inhibitory effect on malignant cells, implicating a 
protective effect for normal tissues. In PC-3 human prostate cancer cells, curcumin in 
combination with phenethyl isothiocyanate induced apoptosis in an additive manner [45]. In this 
study, experiments were limited to concentrations relevant for apoptosis induction; therefore 
combination effects at lower concentrations were not determined. The same group also 
investigated the combined inhibitory effects of curcumin and PEITC on the growth of human PC-
3 prostate xenografts in immunodeficient mice. While PEITC or curcumin alone had little effect, 
the mixture of both significantly reduced the growth of PC-3 xenografts [46].  
Broccoli extracts represent a natural combination of ITCs and indoles. In mature broccoli about 
70% of the glucosinolates are indole-based. The main compound is glucobrassicin as the 
precursor of DIM. The rest consists of different other glucosinolates, especially glucoraphanin, 
the cleavage of which leads to the formation of SFN [47]. In a very recent study broccoli extracts 
induced G2/M cell cycle arrest and apoptosis in cultured rat glial cells [48]. Although the authors 
did not quantify concentrations of glucosinolate cleavage products, in comparison with the results 
presented here it can be speculated that either SFN was present in excess or that its concentration 
was high enough to induce a halt of the cell cycle in G2/M. Another report described 
mitochondria-mediated apoptosis and S-/M phase arrest in human bladder carcinoma cells 
induced by broccoli sprout extract [49]. Broccoli sprouts primarily (> 90%) contain glucoraphanin 
and consequently SFN after conversion to ITCs [47]. Notably, comparison with synthetic SFN 
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revealed that the anti-proliferative potency of the extract was almost identical to that of the single 
compound, suggesting that non-ITC substances in the extract may not interfere with growth-
inhibitory activity of ITCs [49]. In future studies, combinations of SFN or DIM together with 
other chemopreventive compounds should be conducted to investigate potential synergistic 
effects. With this respect, DIM and paclitaxel were shown to synergistically induce apoptosis in 
HER2/Neu human breast cancer cells [50].  
Although progress is made in understanding combinatory effects between bioactive compounds 
present in natural foods, more research efforts are needed in order to elucidate mechanistic 
interactions and dose-dependent differences in the outcomes of combination treatments. The 
concept of combination chemoprevention should be paid more attention as it holds great potential 
for targeted prevention or preventory treatment of malignancies while causing little side effects. 
Transfer of promising findings achieved with single food components to the consumption of 
whole foods should however be done with caution.  
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Figure legends: 
 
Fig. 1. Chemical structures of SFN and DIM. 
 
Fig. 2. Profiles of cell growth inhibition. Growth curves of SFN (), DIM () and the 1:1 
mixture of SFN and DIM (), respectively, with cultured 40-16 cells. Inhibition of cell 
proliferation was determined by sulforhodamine B staining. Cells were treated with eight different 
concentrations of SFN and DIM alone (0.3 to 40 µM), a 1:1 mixture of SFN and DIM (0.15 to 20 
µM of each drug) or 0.5% DMSO as a solvent control for 48 h. Mean values from three 
independent experiments (± SD) are expressed as affected fraction (fa) compared with control 
cells. Dose-dependent inhibition of proliferation is indicated by fa values between 0 and 0.5, 
whereas values above 0.5 represent cytotoxic effects. 
 
Fig. 3. Median-effect plot of 40-16 cells treated for 48 h with SFN (), DIM (), a 1:1 mixture 
of SFN and DIM (), respectively, or 0.5% DMSO as a solvent control. Data were taken from 
one representative cell proliferation experiment. Log (fa/fu) was plotted against log (D), whereby 
fa and fu stand for affected fraction and unaffected fraction, respectively, and D stands for the 
concentration.  
 
Fig. 4. CI-effect plot. CI (combination index) values obtained from cell proliferation experiments 
with 40-16 cells treated for 48 h with a 1:1 mixture of SFN and DIM or 0.5% DMSO as a solvent 
control were plotted against the effects (equivalent to affected fraction fa) mediated by five 
different concentrations (2.5, 5, 10, 20 and 40 µM total concentration) of this drug combination, 
respectively. Data are derived from three independent experiments.  
 
Fig. 5. CI values of combinations of SFN and DIM. 40-16 cells were treated with combinations of 
SFN and DIM in ratios of 1:4, 1:2, 1:1, 2:1 and 4:1 or 0.5% DMSO as a solvent control for 24 h 
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(A), 48 h (B) and 72 h (C). CI values were calculated as described in Materials and Methods. All 
original data were normalized to fixed total concentrations of 2.5, 5, 10, 20 and 40 µM as 
indicated. Data are means ± SD from three independent experiments (exception: n=2 for the 1:4 
combination after 72 h). 
 
Fig. 6. Cell cycle analyses. 40-16 cells were treated with SFN alone, DIM alone, combinations of 
SFN and DIM at ratios of 1:4, 1:2 and 1:1, or 0.5% DMSO as a solvent control for 24 h (A) and 
48 h (B). The concentrations used are indicated in the figure. Cell cycle analyses of fixed cells 
were performed by flow cytometry after staining DNA with propidium iodide. Bars represent the 
percentage of cells in sub-G1, G0/G1, S and G2/M cell cycle phases. Data are means ± SD from at 
least three independent experiments. *Means significantly (p < 0.05) different compared to 
respective control using one-way ANOVA und Tukey’s studentized range test. sMeans 
significantly (p < 0.05) different compared to SFN at a 5 µM concentration in the case of the 5 
µM SFN + 20 µM DIM combination or to SFN at a 10 µM concentration in the case of the 10 µM 
SFN + 10 µM DIM combination, respectively. dMeans significantly (p < 0.05) different compared 
to DIM at a 10 µM concentration. 
 
Fig. 7. Detection of apoptosis induction by PARP cleavage. Immunoblotting for PARP using 
lysates from 40-16 cells treated with 0.2% DMSO (–), SFN, and DIM, alone and in combinations, 
respectively, for 24 h and 48 h as indicated. PARP cleavage was investigated by Western blotting 
using an antibody directed against full length PARP (116 kDa) and the cleavage product (89 
kDa). Equal loading was confirmed by using an anti-β-actin antibody. One of two blots is shown.  
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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IV. DISCUSSION 
According to epidemiological studies, a high consumption of brassica vegetables like 
broccoli, cabbage, Brussels sprouts or cauliflower is associated with a lower risk of 
developing cancer. This has mainly been attributed to secondary plant ingredients present 
in cruciferous vegetables, namely glucosinolates. Glucosinolates are thioglucosides, 
which are cleaved into isothiocyanates and indole derivates by the plant-endogenous 
enzyme myrosinase upon plant cell damage. One of the most prominent and intensively 
studied isothiocyanates is sulforaphane (SFN). SFN is especially known for its ability to 
modulate xenobiotic biotransformation by inhibiting phase I- and inducing phase II 
enzymes. Chemopreventive efficacy of SFN has been demonstrated in several animal 
models. In recent years, SFN was shown to affect other anticancer mechanisms as well, 
including the induction of cell cycle arrest and apoptosis in cultured cancer cells. To 
elucidate the molecular mechanisms of SFN’s action is essential for the development of 
functional food/agents suitable for chemopreventive or -therapeutic applications.  
 
The results of the present thesis contribute to a better understanding of the mechanisms 
involved in SFN-induced apoptosis induction. In the human colon cancer cell line 40-16 
SFN is shown to induce a marked cell cycle arrest in M phase due to microtubule 
disruption and activation of the spindle checkpoint. This mitotic arrest was followed by 
apoptosis, which was demonstrated to depend on caspase activity. Further mechanistic 
investigations revealed that the mitochondrial pathway of apoptosis was activated, since 
SFN-induced apoptosis was blocked in Bcl-2 overexpressing Jurkat leukemia cells. The 
inhibition of NF-κB activation facilitated apoptosis induction with the result of a 
decreased expression of anti-apoptotic proteins like XIAP, Bcl-2 and c-FLIP 
(Manuscript 1).  
 
In the literature it is still a matter of controversy whether SFN-induced cell cycle arrest is 
due to an activation of the DNA damage checkpoint or the spindle checkpoint. The 
primary effect of SFN for cell cycle arrest or apoptosis induction is also unclarified: Do 
these two effects occur independently from each other or is one the prerequisite for the 
other? In the present study, it could clearly be shown that the mitotic arrest was SFN’s 
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primary effect, and apoptosis a consequence of spindle disruption (Manuscript 1). The 
applied methodology was Flow cytometric analysis of cells stained with the mitosis-
specific antibody MPM-2. The results were confirmed by using the well-known 
antimitotic agent paclitaxel as positive control. In extension of these experiments and to 
further confirm the results, immuncytochemistry with an anti-tubulin antibody might be 
performed to score the abundance of prophase/promethaphase-like mitotic figures. In 
addition, it would be interesting to analyse factors involved in the regulation in G2/M 
transition like Cdk1 and cyclin B1 in terms of gene expression, protein levels and 
phosphorylation status. To exclude the possibility that SFN induces the DNA damage 
checkpoint in the 40-16 cell line, the DNA damaging agent Methyl methanesulfonate 
(MMS)-induced G2/M arrest was demonstrated to be abrogated by caffeine, which is 
known to block DNA damage-induced cell cycle arrest in G2. Since the G2/M phase arrest 
induced by SFN was not inhibited by caffeine it was concluded that SFN does not induce 
the DNA damage checkpoint. However, these investigations were of rather indirect 
nature. To confirm the results, the genotoxic potential of SFN should be analyzed 
directly, e.g. by performing the Comet assay.      
 
In a recent report Singh et al. suggested that the formation of reactive oxygen species 
(ROS) may be the initial signal for SFN-induced apoptosis [Singh et al., 2005]. The 
authors used cultured PC-3 prostate cancer cells for their experiments and found 
mitochondrial- as well as nonmitochondrial mechanisms involved in ROS production. 
However, the same authors also reported a ROS-mediated G2 cell cycle arrest and the 
induction of autophagy by SFN preceding apoptosis, all in the PC-3 cell line [Singh et al., 
2004; Herman-Antosiewicz et al., 2006]. It was suggested that apoptosis and the G2 arrest 
were induced by SFN independently, and that apoptosis could also be a result of the cell 
cycle arrest. Autophagy was suggested to inhibit apoptosis induction by SFN and might 
be the reason for the delayed cell death. 
In the present study, ROS formation after SFN treatment for 1 h, 3 h and 6 h was 
investigated in the 40-16 cell line using the ROS-sensitive dye 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) and Flow cytometric analysis. No 
significant elevation of ROS was detectable for any time point, in contrast to the above-
mentioned studies. Thus, SFN’s mechanisms of action seem to depend strongly on the 
cell type. A reduction of intracellular glutathione (GSH) levels is often associated with 
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oxidative stress and the formation of ROS [Townsend et al., 2003]. Although no increase 
in ROS was observed in the present thesis, a significant GSH depletion was detected, 
peaking in the time range of four to six hours of treatment with SFN. At subtoxic 
concentrations, GSH levels were induced again after 24 h due to enhanced resynthesis 
(Manuscript 2). These results led to the conclusion that GSH depletion was not a 
prerequisite for SFN-induced apoptosis. Supporting this, significant GSH depletion 
induced by L-buthionine-S,R-sulfoximine (BSO), a specific inhibitor of γ-glutamyl-
cysteine synthetase, did not result in any cytotoxic effects in the 40-16 cell line. 
For determining GSH levels, a colorimetric assay based on the oxidation of thiols by 5,5'-
dithiobis(2-nitrobenzoic acid) (DTNB; also called Ellman’s reagent) was performed. This 
is a well-accepted method to measure the cellular GSH content, although strictly speaking 
not only GSH, but also other thiols present in the cell are detected. To get a more precise 
picture of changes in the levels of reduced and oxidized GSH, either HPLC analysis or 
the fluorescence dyes monochlorobimane or monobromobimane should be used, which 
form fluorescent adducts with reduced GSH upon catalytic activity of GSTs. For the 
analysis of ROS formation, cell staining with the dye H2DCFDA could be performed in 
96-well plates rather than for Flow cytometric analysis in order to reduce trypsinization 
stress and the consequent high background levels of ROS. 
 
In the present study, as well as in other studies, SFN was shown to inhibit the activation 
of NF-κB (Manuscript 1). Among others, oxidative stress within the cell is a common 
trigger for NF-κB activation. Therefore the question remains whether an increase in ROS 
and the inhibition of NF-κB activation can be induced by SFN simultaneously. In most 
studies, this has not been investigated in a single cell line with the same SFN 
concentration. At relatively high concentrations (25 and 50 µM) SFN even activated NF-
κB along with increased ROS production in Caco-2 human colon cancer cells 
[Jakubikova et al., 2006].   
Due to these discrepancies, it can be hypothesized that not ROS formation but rather thiol 
reactivity may be the main mode of action of SFN. SFN is known to be a reactive 
Michael acceptor type-compound, which rapidly binds to thiol groups, leading to 
dithiocarbamate formation [Zhang & Talalay, 1994]. SFN-mediated induction of phase II 
enzymes was found to be due to its thiol reactivity. Binding of SFN to specific sulfhydryl 
groups of the sensor protein Keap1 activates the Nrf2 pathway, leading to ARE-mediated 
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induction of phase II detoxifying enzymes [McMahon et al., 2001; Dinkova-Kostova et 
al., 2002].  
 
An interaction of SFN with thiol groups has also been proposed as a mechanism 
underlying SFN-mediated NF-κB inhibition. In Raw 264.7 macrophages SFN prevented 
active NF-κB from binding to its nuclear DNA sites via a thiol-mediated mechanism, 
presumably by dithiocarbamoylation of NF-κB subunits or of factors involved in the 
redox regulation of NF-κB [Heiss et al., 2001]. NF-κB requires oxidative conditions for 
activation and nuclear translocation, but a reductive environment for DNA binding in the 
nucleus [Anderson et al., 1994]. However, in the present study SFN inhibited NF-κB 
upstream of its translocation into the nucleus (Manuscript 1). Thus, the above-mentioned 
mechanism can not apply for the 40-16 cell line. Since others have shown that SFN 
treatment resulted in reduced phosphorylation of IKK-β [Xu et al., 2005], it can be 
speculated that SFN may interfere with the most upstream signaling events of the NF-κB 
pathway by specific thiol-modifications. Future investigations should verify that these 
mechanisms are not cell-type specific and e.g. also apply for the cell line used in this 
study.  
In order to understand the importance of NF-κB inhibition in SFN-induced apoptosis 
induction more mechanistic investigations are needed. One possibility would be to 
generate cell lines stably overexpressing p65- or p50 NF-κB and to see whether a strong 
constitutive NF-κB activation renders the cells resistant toward SFN treatment. 
 
In the present thesis kinetic experiments were performed with SFN in order to investigate 
the effects of short exposure times, as well as the effect of drug removal on cell cycle 
arrest and apoptosis in the 40-16 cell line. It could be demonstrated that cell growth 
inhibition by SFN follows a biphasic pattern: transient exposure for up to 6 h resulted in 
reversible G2/M cell cycle arrest and cytostatic growth inhibition even at elevated 
concentrations, whereas a minimum continuous exposure time of 12 h was necessary for 
SFN to irreversibly arrest cells in G2/M and subsequently induce apoptosis (Manuscript 
2). These findings are of major importance when results of in vitro studies are transferred 
to the human situation. Due to rapid metabolism of SFN in the human body it is unlikely 
that a continuous exposure of 12 h or longer is achievable. In the colon however, also 
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taking the local release of SFN from intact glucosinolates into account, a longer exposure 
time could be feasible. These matters should be investigated in future studies. Apart from 
the effect of a single treatment with SFN, the impact of repeated dosing in well-defined 
time intervals should also be analyzed in vitro to see whether that could be equally 
effective compared with continuous dosing. In most animal studies treatments are 
performed in intervals to observe long-term effects. As an alternative, the agent to be 
administered is given with the food, so that dosing intervals depend on the eating habits 
of the animals. With both treatment regimens, chemopreventive efficacy of SFN in the 
intestine could be demonstrated: by the suppression of AOM-induced ACF formation in 
the rat colon, and by the inhibition of tumorigenesis in ApcMin/+ mice, respectively [Chung 
et al., 2000; Hu et al., 2006; Myzak et al., 2006]. In one of the studies conducted with 
ApcMin/+ mice, gene expression analysis of small intestinal polyps revealed that genes 
involved in apoptosis and cell growth regulation were modulated strongest by SFN 
treatment [Khor et al., 2006]. Moreover, SFN selectively induced apoptosis in the 
intestinal adenomas but not in the normal mucosa [Hu et al., 2006]. In conclusion of these 
findings, apoptosis induction definitely plays a role in vivo. Consistently, Conaway et al. 
detected a significant induction of apoptosis markers in lung tumors of mice treated with 
SFN after tumor initiation by tobacco carcinogens [Conaway et al., 2005]. Taken 
together, these results clearly show that concentrations relevant for apoptosis induction 
can be reached in tumor cells of animals orally receiving SFN, and that the duration of 
exposure to the chemopreventive agent was obviously long enough to effectively induce 
apoptosis. 
 
One concern often raised with respect to apoptosis induction as a chemopreventive 
mechanism is whether cell death induction selectively takes place in initiated cells while 
normal cells are left unaffected. Studies with cultured cells have indicated that those cell 
lines with a higher malignancy status were more sensitive toward SFN treatment than 
more differentiated cell lines. Gamet-Payrastre et al. reported that the colon cancer cell 
line HT29 was significantly more susceptible toward SFN than undifferentiated Caco-2 
cells, also derived from a colon cancer, indicating selective cytotoxicity [Gamet-Payrastre 
et al., 1998]. In another study the nontumorigenic colon cell line HCEC was resistant to 
SFN treatment with no signs of apoptosis induction as opposed to the transformed colon 
cancer cell lines LS-174 and Caco-2 [Bonnesen et al., 2001]. In contrast to these studies, 
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others observed marked apoptosis induction in non-transformed human T lymphocytes 
after treatment with SFN, similar to that in Jurkat T leukemia cells [Fimognari et al., 
2003]. Nevertheless, in animal studies no adverse effects were observed in rats or mice 
treated with SFN [Chung et al., 2000; Hu et al., 2006; Myzak et al., 2006].    
 
SFN appears to exert its anti-proliferative effects selectively in tumor cells. A possible 
reason for this phenomenon could be the fact that tumor cells are actively dividing, 
whereas normal cells usually have a lower mitotic index, especially when they are 
differentiated. In the colon, epithelial cells undergo a rapid turnover and are constantly 
renewed by newly differentiated cells derived from stem cells located in the crypts of the 
colon. Thus, those cells exposed to the lumen are non-dividing differentiated cells and 
presumably relatively resistant toward ITC cytotoxicity. Since cells with a high mitotic 
index appear to be particularly susceptible to SFN, it is likely that SFN affects 
components of the mitotic machinery, as already proposed above. Supporting this 
assumption, synchronized HT29 colon cancer cells treated with SFN were not able to 
reenter cell cycle, but cell proliferation was initiated without signs of cytotoxicity after 
SFN removal [Gamet-Payrastre et al., 1998]. Thus, resting cells in G0 seemed to be 
resistant toward SFN treatment.  
Further research is needed to elucidate the molecular mechanisms of cancer cell growth 
inhibition by SFN. From what is known so far, mechanisms appear to differ substantially 
between cell types and depend on the genetic background of the cell line used. These 
discrepancies limit the possible appliance of SFN for the prevention of cancers in humans 
and further underline the need for sophisticated in vitro- as well as in vivo studies. 
 
Natural foods are composed of a variety of different ingredients. Apart from water, fiber, 
carbohydrates, proteins, fats, vitamins and minerals, various different secondary plant 
metabolites with a potential accessory function can be found in vegetables. Unique and 
characteristic for brassica vegetables are glucosinolates, which are thought to be 
responsible for the cancer preventive effects of a diet rich in cruciferous vegetables. For 
the investigation of the mechanisms underlying these effects, mostly single isolated 
glucosinolate cleavage products are being used. Promising findings achieved with single 
compounds are then often transferred to the whole food. Thereby possible combinatory 
interactions between the different compounds present in whole vegetables are often 
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disregarded, mainly because there is a lack of knowledge. In the present study, 
combination effects were investigated between SFN and the indole derivate 3,3’-
diindolylmethane (DIM), both derived from broccoli (Manuscript 3). These two 
compounds were chosen, since their precursor glucosinolates are the predominant 
glucosinolates in broccoli, and since SFN and DIM were found to exert their 
chemopreventive activities by different mechanisms [Fahey et al., 2001].  
Both SFN and DIM have the ability to modulate gene expression of drug metabolizing 
enzymes. Indoles like indole-3-carbinol and DIM are known to be bifunctional inducers 
of biotransformation enzymes, whereas ITCs like SFN are monofunctional inducers and 
thus only associated with the induction of phase II enzymes [Prestera et al., 1993]. 
Not only with respect to modulation of biotransformation, but also in terms of cancer cell 
growth inhibition the modes of action of SFN and DIM appear to be different. It was 
recently demonstrated that ITCs like SFN are cytotoxic in human colon cancer cell lines, 
whereas indoles like DIM are acting by a cytostatic mechanism [Pappa et al., 2006]. 
Although IC50 values of SFN and the aromatic ITC phenethyl isothiocyanate were similar 
to those of indole-3-carbinol and DIM, the indole derivates inhibited cell growth without 
cytotoxicity, whereas the ITCs reduced the original cell number to almost zero. Another 
striking difference between these two groups of glucosinolate cleavage product is that 
indoles were shown to halt the cell cycle in G1 [Aggarwal & Ichikawa, 2005], while ITCs 
induce cell cycle arrest in G2/M phase [Zhang et al., 2006]. 
As an endpoint for the investigation of combination effects between SFN and DIM, anti-
proliferative activity was taken into account using a cytotoxicity assay. 40-16 cells were 
treated with defined ratios of the two compounds or SFN and DIM alone (Manuscript 3). 
For quantitative evaluation of combinatorial interactions Chou and Talalay have 
developed a method which has become the “golden standard” for these type of 
investigations [Chou & Talalay, 1984].  
The first step of this procedure is to assess whether the two compounds of the 
combination are mutually exclusive (same receptor or same mode of action) or mutually 
non-exclusive (different modes of action). This is accomplished by generating a median-
effect plot, in which parallelism of the regression lines of the two single compounds and 
the combination indicates mutual exclusivity. If the three regression lines are not in 
parallel the drugs are mutually non-exclusive and thus act by distinct modes of action. In 
the case of SFN and DIM the regression lines were not in parallel for any of the mixtures 
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applied (Manuscript 3). Thus, SFN and DIM are mutually non-exclusive. This finding 
was in congruence with the earlier mentioned differences between SFN and DIM with 
regard to mechanisms of gene expression modulation and cell growth inhibition.  
The next step of the Chou-Talalay approach is the calculation of the combination index 
(CI). Thereby the doses of each drug in the combination needed to produce a given effect, 
e.g. 50% growth inhibition, are calculated in relation to the doses of each drug alone 
needed to produce the same effect. A CI < 1, CI = 1 and CI > 1 indicates synergism, 
additivity and antagonism, respectively. For the combinations of SFN and DIM the CI 
values corresponding to fixed total drug concentrations were calculated to be able to 
compare different mixtures. It was found that combinatory interactions between SFN and 
DIM were strongly dose-dependent, in that low concentrations were antagonistic, whereas 
cytotoxic concentrations were synergistic, regardless of the ratio applied (Manuscript 3). 
An explanation for these results could be the strong ability of SFN to enhance 
detoxification at low concentrations. Also consistent with this assumption, synergism 
between ITCs and indoles was reported in terms of phase II enzyme induction [Staack et 
al., 1998; Nho & Jeffery, 2001]. This is probably due to the different mechanisms of 
modulating gene expression of these two types of glucosinolate cleavage products. 
 
In the present study, mixtures of SFN and DIM were not only tested in a cytotoxicity 
assay, but also in Flow cytometric analysis of cell cycle distribution. Quantification of 
combination effects by CI calculations was not possible with cell cycle data, because 
values between 0 and 1 are needed. Due to the distribution of cells in four cell cycle 
phases this kind of quantitative evaluation could not be performed. Nevertheless, results 
clearly confirmed the data obtained with the cytotoxicity experiments (Manuscript 3). 
Low concentrations of the mixtures were antagonistic and the highest concentrations were 
synergistic with respect to the induction of cell cycle arrest and apoptosis. Interestingly, 
when the SFN concentration in the mixture exceeded 5 µM, a marked G2/M arrest was 
observed. Thus, it can be hypothesized that a certain threshold concentration of SFN is 
necessary to induce spindle damage. Below that concentration SFN’s main effect is the 
modulation of gene expression. The threshold concentration of SFN to induce mitotic 
arrest was lowered in combination with DIM, although DIM alone was reported to rather 
induce a cell cycle arrest in G1 phase. Considering these results, it is even more likely that 
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the consumption of brassica vegetables can give rise to ITC and indole concentrations 
sufficient for cancer cell growth inhibition in humans.  
Synergistic interactions of DIM in combination with a microtubule-damaging agent have 
been described before. In HER2/Neu human breast cancer cells DIM and paclitaxel were 
shown to synergistically induce apoptosis [McGuire et al., 2006]. This finding is of great 
clinical relevance since some tumors are resistant to treatment with antimitotic agents 
[Geney et al., 2005]. The mechanisms underlying this synergistic interaction have to be 
elucidated in future studies.   
 
Combination chemotherapy is increasingly investigated and already successfully applied 
in the clinic. Especially in tumors with acquired resistance to certain agents a sensitization 
can offer great treatment advantages. Moreover, in most cases of combination therapy 
adverse side effects are reduced.  
In chemoprevention research, clinical trials conducted with isolated compounds have 
often led to disappointing outcomes. For instance, in the α-tocopherol, β-carotene cancer 
prevention study (ATBC) lung cancer incidences were increased in subjects taking β-
carotene [1994]. As another example, two large randomized trials that examined the 
effects of fiber supplementation on colorectal adenoma recurrence failed to show a 
chemopreventive effect [Schatzkin et al., 2000]. Possible synergistic interactions among 
the different ingredients in whole foods could explain the lack of efficacy obtained with 
single compounds as well as the fact that numerous case control studies showed inverse 
correlations between cancer incidences and the consumption of certain types of food. 
Therefore the field of combination chemoprevention should be paid more attention. 
Clinical trials conducted with defined combinations of chemopreventive agents could lead 
to more promising results. Moreover, the molecular mechanisms of chemopreventive 
action as well as of combinatorial interactions should be the focus of future research. 
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V. SUMMARY 
Introduction: Isothiocyanates and indole derivates derived from brassica vegetables are 
promising chemopreventive compounds. Sulforaphane (SFN), the predominant 
isothiocyanate from broccoli, is known to interfere with all phases of carcinogenesis, 
including the ability to induce cell cycle arrest and apoptosis in cancer cells. However, the 
molecular mechanisms of these effects are largely unresolved so far and were a matter of 
investigation in the present thesis. Since isothiocyanates and indole derivates occur 
concomitantly in broccoli, combination effects between SFN and 3,3’-diindolylmethane 
(DIM) were investigated in terms of cell growth inhibition. 
Methods: In the human colon cancer cell line 40-16, cell cycle effects were analyzed 
using Flow cytometry after staining the DNA with propidium iodide. To investigate 
necrosis induction and the accumulation of cells in mitosis, the propidium iodide 
exclusion assay and labeling of cells with the mitosis-specific antibody MPM-2 were 
utilized, respectively. NF-κB activation was determined by an ELISA-based assay. The 
potential-sensitive fluorescent dye JC-1 was used to investigate the mitochondrial 
membrane potential. The expression of proteins involved in apoptosis and NF-κB 
activation was analyzed by Western Blotting. A Jurkat cell line stably overexpressing 
Bcl-2 was a tool to explore the involvement of the mitochondrial pathway of apoptosis. 
Sulforhodamin B staining was used to assess the inhibition of cell proliferation. Cellular 
glutathione levels were measured with a colorimetric assay using Ellman’s reagent. 
Combination effect between SFN and DIM were calculated base on the method of Chou 
and Talalay (1984). 
Results: SFN induced a cell cycle arrest in G2/M phase, which was demonstrated to be 
due to the activation of the spindle checkpoint. Apoptosis was a consequence of this 
mitotic arrest. Cell death induction was found to be due to the activation of the 
mitochondria-mediated pathway. In addition, SFN strongly inhibited NF-κB activation 
upstream of its translocation into the nucleus, leading to the downregulation of different 
anti-apoptotic proteins. Kinetic experiments revealed that a minimum continuous 
exposure time of 12 h was necessary for SFN to irreversibly arrest cells in mitosis and 
subsequently induce apoptosis. Depletion of glutathione does not seem to play a role in 
SFN-mediated apoptosis induction. Combinations of SFN and DIM at different molar 
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ratios inhibited cell growth in an antagonistic manner at low concentrations, whereas 
cytotoxic concentrations were synergistic.  
Conclusions: The results of this thesis contribute significantly to the knowledge about the 
molecular mechanisms and kinetics of SFN-induced cell cycle arrest and apoptosis in 
human cancer cells. Moreover, this study provides insights into combinatorial interactions 
between the two broccoli compounds SFN and DIM, which represent a valuable 
contribution to the understanding of possible combined effects of food compounds, an 
important aspect of chemoprevention research.  
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VI. ZUSAMMENFASSUNG 
Einleitung: Isothiocyanate und Indolderivate aus Kohlgemüse sind Erfolg versprechende 
chemopräventive Substanzen. Sulforaphan (SFN), das dominierende Isothiocyanat aus 
Brokkoli, interferiert mit allen Phasen der Karzinogenese, einschließlich der Fähigkeit in 
Krebszellen Zellzyklusarrest und Apoptose auszulösen. Die molekularen Mechanismen 
dieser Effekte sind jedoch bisher zum Großteil unbekannt und stellen daher den 
Untersuchungsgegenstand der vorliegenden Arbeit dar. Da Isothiocyanate und 
Indolderivate gemeinsam in Brokkoli vorkommen, wurden Kombinationseffekte 
zwischen SFN und dem Indol 3,3’-Diindolylmethan in Bezug auf die Hemmung des 
Zellwachstums untersucht.  
Methoden: In der humanen Kolonkrebszelllinie 40-16 wurden Zellzykluseffekte mittels 
Färbung der DNA mit Propidiumiodid und anschließender Durchflusszytometrie 
analysiert. Für die Erfassung nekrotischer und mitotischer Zellen wurde der “propidium 
iodide exclusion assay“, bzw. das Markieren der Zellen mit dem mitosespezifischen 
Antikörper MPM-2 durchgeführt. Die Aktivierung von NF-κB wurde mittels einer 
ELISA-basierten Methode erfasst. Der potentialsensitive Fluoreszenzfarbstoff JC-1 wurde 
für die Untersuchung des mitochondrialen Membranpotentials verwendet. Die Expression 
von Proteinen, die bei der Apoptose und der NF-κB Aktivierung eine Rolle spielen 
wurden mittels Western Blot analysiert. Als Hilfsmittel, um die Beteiligung des 
mitochondrialen Signalwegs der Apoptose zu erforschen, wurde eine Bcl-2 
überexprimierende Jurkat Zelllinie eingesetzt. Sulforhodamin B Färbung wurde für die 
Erfassung von Zellwachstumshemmung verwendet. Die Messung von zellulärem 
Glutathion wurde mit Ellman’s Reagenz und colorimetrischer Bestimmung erfasst. 
Kombinationseffekte zwischen SFN and DIM wurden nach der Methode von Chou and 
Talalay (1984) ausgewertet.  
Ergebnisse: SFN induzierte einen G2/M Zellzyklusarrest, der auf die Aktivierung des 
Spindel-Kontrollpunkts zurückgeführt werden konnte. Apoptose war eine Konsequenz 
dieses mitotischen Arrests. Es konnte gezeigt werden, dass Apoptose über den 
mitochondrialen Signalweg ausgelöst wurde. Weiterhin hemmte SFN die Aktivierung von 
NF-κB vor dessen Translokation in den Nukleus, was zur Herunterregulation 
verschiedener anti-apoptotischer Proteine führte. Kinetische Experimente ergaben, dass 
eine minimale Expositionszeit von 12 h nötig war, um unumkehrbar Mitosearrest und 
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Apoptose auszulösen. Die Depletion von Glutathion scheint keine Rolle für die durch 
SFN ausgelöste Apoptose zu spielen. Kombinationen von SFN und DIM in verschiedenen 
molaren Verhältnissen hemmten das Zellwachstum auf antagonistische Art und Weise bei 
niedrigen Konzentrationen, wogegen cytotoxische Dosen synergistisch wirkten.  
Schlussfolgerungen: Die Ergebnisse dieser Arbeit leisten einen signifikanten Beitrag 
zum Wissen über die molekularen Mechanismen und die Kinetik von SFN-induzierter 
Zellzyklusarrettierung und Apoptoseinduktion in humanen Krebszellen. Des Weiteren 
bietet diese Studie Erkenntnisse über kombinatorische Interaktionen zwischen den zwei 
Brokkoli-Substanzen SFN und DIM, was zu einem besseren Verständnis von möglichen 
Kombinationseffekten zwischen Lebensmittelinhaltsstoffen beiträgt, einem wichtigen 
Aspekt der Chemopräventionsforschung.    
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